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This thesis comprises part A and part B. Part A is about the stereoselective 
synthesis of threo-β-amino-a-hydroxy acids from the N-hydroxymethyl 
protected a-amino aldehydes. threo-β-Amino-a-hydroxy acids, frequently 
found in naturally occurring bioactive compounds, have been synthesized via 
the stereoselective intramolecular conjugate addition of N-hydroxymethyl 
group, which configurationally stabilizes an a-amino aldehyde by forming the 
hemiacetal. In this study, the stable a-amino aldehyde was reacted with 
phenylsulfonylnitromethane (PhSO2CH2NO2) to afford stereoselective trans-
oxazolidine, which was a precursor for threo-β-amino-a-hydroxy acid. The 
three tandem reactions between phenylsulfonylnitromethane and the a-amino 
aldehydes and the followed in-situ ozonolysis affored trans-oxazolidine 
methyl esters (A23) in 65% to 69% yields with more than 20 to 1 
stereoselectivity. Bestatin, a well-known aminopeptidase inhibitor, was 
stereoselectively synthesized in 83% yield from trans-oxazolidine methyl 
ester A23-Phe, which was derivated from D-Phe-OH. Leucinal and valinal 
derivatives (A23-Leu, and A23-Val) were successfully applied for the 
synthesis of the corresponding threo-vicinal amino alcohol embeded 
dipeptides at N-terminus, which were the first synthesized isobutyl and 
isopropyl substituted bestatin analogs. Moreover, two stereoselective 
dipeptides, containing (2S,3R), or (2R,3S)-3-amino-2-hydroxy-4-
methylpentanoic acid at N-terminus, were synthesized to elucidate the 
stereochemistry of naturally occurring another aminopeptidase inhibitor 
lapstatin from the commercially available Boc-D-Val-OH or Boc-L-Val-OH. 
i 
 
trans-Oxazolidine methyl ester from D-Ser-OH (A23-Ser) was 
stereoselectively converted to the glutamate transporter blocker L-threo-β-
benzyloxy aspartic acid (L-TBOA) via the simple functionalization of 
hydroxymethyl of the oxazolidine A23-Ser and following selective benzyl 
protection of hydroxyl group.       
In part B, a new process development for acetaminophen has been presented. 
In the new proces, two copper catalyzed reactions were applied with p-
dihalobenzenes for practical and efficient synthesis of acetaminophen. N-
Acetylamidomethyl and hydroxyl group on acetaminophen were 
regioselectively introduced via Goldberg reaction with acetamide and 
Ullmann type condensation reactions in the presence of copper catalysts and 
diamine ligands. Furthermore, the suggested efficient two-step process was 
successfully simplified as one-pot process by excluding the purification of the 
intermediate, N-acetyl-p-haloaniline. Under the optimized one-pot process, 
acetaminophen was obtained in 74% yield from the commercially available p-
bromoiodobenzene. 
 
Keywords: threo-β-amino-a-hydroxy acids, stereoselective intramolecular 
conjugate addition, aminopepetidase inhibitors, L-threo-β-benzyloxy aspartic 
acid, acetaminophen, copper-catalyzed amidation, copper-catalyzed 
hydroxylation.  
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Applications of N-hydroxymethyl protected a-





1. Introduction of stable a-amino aldehydes  
There had been a few configurationally stable a-amino aldehydes due to the 
chemically and configurationally labile proton at a-position on the a-amino 
aldehyde even though they were useful chiral synthons in asymmetric 
synthesis.1 The reported stable a-amino aldehydes and their limitations were 











Garner aldehyde Falorni aldehyde Rapoport aldehyde Reetz aldehyde
only applicable to a limited amino acids





Figure A1. Reported a-amino aldehydes. 
 
 In order to overcome the limitations, a saturated hemiacetal group was 




which was suggested by Ito et al.3 The conversion of carbonyl group to the 
saturated hemiacetal would be completed by the introduction of an N-
hydroxyalkyl group to the aldehyde. With Boc protected phenylalamine, the 
stable a-amino aldehyde was prepared via the condensation with 
paraformaldehyde (A1) and the following reduction to the corresponding 






















 Scheme A1. The preparation of a stable a-amino aldehyde. 
  
The stability of the prepared a-amino aldehyde A2 was confirmed by the 
weathering test with diol compounds (not shown), which was obtained by the 
reduction of the lactol A2 with LAH.4 Careful analysis of 1H NMR spectra 
indicated 1-1.5% racemization during the preparation of lactol A2, and no 
racemization was observed during storage at room temperature. However, 
additional 1-1.5% racetamization was observed when the sample stored at 
room temperature for a month. The stabilizing effect from the N-
hydroxymethyl group was quite evident compared with 3-5% racemization 




2. The application of N-hydroxymethyl group  
in the stereoselective syntheses of g-amino-β-hydroxy acids 
 
 The N-hydroxymethyl group on the stable a-amino aldehyde (A2) did not 
only stabilize the labile a-amino aldehyde by forming lactol, but also was 
utilized as a crucial element for the intramolecular conjugate addition. threo-
g-Amino-β-hydroxy acids, found in a number of bioactive natural compounds 
like peptide enzyme inhibitors, amino sugar antibiotics, alkaloids and 
sympathomimetic amines,5 had been efficiently synthesized with the stable a-
amino aldehydes. The intramolecular conjugate addition between the N-
hydroxymethyl and the introduced internal electrophile a,β-unsaturated 





















A4 A3  
Scheme A2. Retroscheme for g-amino-β-hydroxy acids. 
 
 Contrast to the previously reported a-amino aldehydes, such as Garner 
aldehyde and Falorni aldehyde, the hemiacetal form of the stable a-amino 
aldehyde A2 could be synthesized from various amino acids. From the 
practical advantage on the preparation of lactol A2, the synthetic method for 




aminodeoxy statin, β-hyroxyglutamic acid and threo-AHPPA from the 
commertically available Boc-Leu-OH, Boc-Ser-OH and Boc-Phe-OH. 
Moreover, the developed synthetic method had been expended to synthesize 
erythro-AHPPA via the intramolecular epoxidation with N-









































Scheme A3. Synthesis of (-)-statin with the N-hydroxymethyl group. 
 
The first application was started with the preparation of lactol from Boc-L-
Leu-OH (Scheme A3).6 With the synthesized leucinal derivative A2-Leu, the 
introduction of the internal electrophile a,β-unsaturated methyl ester was 
completed via Wittig olefination with stabilized ylide. The prepared (E)-g-
amino-a,β-conjugate ester A3-Leu undergone the intramolecular conjugate 
addition of the N-hydroxymethyl group under the basic reaction condition. 
Therefore, the stereoselective intermediate trans-oxazolidine was synthesized 




was readily converted to enantiomerially pure (-)-statin from the simple 











































Scheme A4. Synthesis of (-)-deoxyaminostatin with N-amidomethyl group. 
 
Based on the successful synethesis of enantiomerically pure (-)-statin, (-)-
aminodeoxystatin,7 one of the derivatives, was synthesized via the same 
intramolecular conjugate addition after converting the N-hydroxymethyl 
group to N-aminomethyl group (Scheme A4). The synthesized 
aminodeoxystatin showed 10 to 1 stereoselectivity, like (-)-statin.  
 The next application of the stereoselective intramolecular conjugate addition 
of the N-hydroxymethyl group was the synthesis threo-β-hydroxy-L-
glutamate (Scheme A5).8 A suitable amino acid for the target compound, Boc-
L-Ser-OH, was readily converted to lactol (A2-Ser) via the same procedure 




under the same reaction conditions with the previous studies where Wittig 
olefination was applied. The disappointed result could be caused by the 
attribution of the apparently smaller alkyl group of the serinal derivative. 
Based on the fact that (Z)-olefins having a stereogenic allylic alcohol usually 
showed higher diasterofacial selectivities in electrophilic addition reactions 
than the case with the corresponding (E)-olefins, the formation of (Z)-olefin 
(A3-Ser) was considered to improve the selectivity. The (Z)-olefination with 
Still’s reagent accompanined the tandom intramolecular conjugate addition 
between the N-hydroxymethyl group and the internal electrophile, and the 



































Scheme A5. Synthesis of threo-β-hydroxy-L-glutamic acid. 
 
Another application of the stereoselective conjugate addition of the N-
hydroxymethyl group was the divergent stereoselective synthesis of threo-
AHPPA and erythro-AHPPA.9 threo-N-Boc-AHPPA was synthesized through 




from Boc-L-Phe-OH in three step (Scheme A6). The stereoselectivity of the 
intramolecular conjugate adduct A4-Phe was estimated at more than 20 to 1. 
The oxidative N, O acetal cleavage of the trans-oxazolidine methyl ester (A4-
Phe) presented O-formylated A10-Phe, and the followed sequential acidic 
and basic hydrolysis afforded N-Boc protected threo-4-amino-3-hydroxy-5-














































Scheme A6. Synthesis of threo-N-Boc-AHPPA. 
 
In the synthesis of erythro-N-Boc-AHPPA, a new synthetic method with the 
N-hydroxymethyl group had been applied to the intramolecular epoxidation 
via the conversion of the N-hydroxymethyl group to the N-
hydroperoxymethyl group.10 Based on the newly developed intramolecular 
epoxidation, anti-epoxide A12-Phe was prepared more than 20 to 1 ratio and 
converted to the N-Boc protected erythro-AHPPA via the removal of N-
hydroxymethyl group and the followed Pd-catalyzed hydrogenation to give 
















































Scheme A7. Synthesis of erythro-N-Boc-AHPPA. 
 
 The following figure showed all of the synthesizsed g-amino-β-hydroxy 



































Figure A2. The synthesized g-amino-β-hydroxy acids. 
 
From the successful application of the N-hydroxymethyl group to the 
stereoselective synthesis of g-amino-β-hydroxy acids,6-10 another series of 
vicinal amino hydroxy acids had been planed as the extension of the 




3. The application of N-hydroxymethyl group  
to the stereoselective synthesis of β-amino-a-hydroxy acids 
 
The development of an efficient synthetic method for β-amino-a-hydroxy 
acids had been an attractive subject since non-proteinogenic amino acids had 
been frequently found in biologically active natural products.11 For example, 
typical β-amino-a-hydroxy acid units were embedded in an anticancer and 
antibacterial agent bestatin,12 an aminopeptidase inhibitor amastatin,13 an 
glutamate transporter blocker L-threo-β-benzyloxyaspartic acid (L-TBOA),14 
and an anticancer paclitaxel15 (Fig. A3). Some β-amino-a-hydroxy acids had 









































Figure A3. β-Amino-a-hydroxy acid units in natural products 
 
Enantiomerically pure β-amino-a-hydroxy acids had been synthesized 
mostly via reagent-controlled synthetic methods such as the asymmetric 
aminohydroxyation,17 the selective opening of a chiral epoxide,18 and the 




 The aminohydroxylation provided one-step stereospecific conversion to the 
protected β-amino alcohols using the catalytic amount of osmium source and 
chiral ligands based on cinchona alkaloids (Scheme A8). However, the 
asymmetric aminohydroxylation required chiral reagents and showed 


















Scheme A8. Sharpless asymmetric aminohydroxylation. 
 
 The opening of a chiral epoxide was another method for high enantiomeric 
excess (Scheme A9). Although high enantiomeric excess and acceptable 
yields had been observed, this method required many reaction steps for the 
preparation of a chiral epoxide and the functionalization after the ring opening, 











Scheme A9. Opening of a chiral epoxide. 
 
In asymmetric Mannich reaction, β-amino-a-hydroxy aldehyde had been 
synthesized with high stereoselectivity. Asymmetric Mannich reaction was 



















Scheme A10. Asymmetric Mannich reaction. 
 
Based on the simplicity and diverse utility of the N-hydroxymethyl group on 
the stable a-amino aldehyde, the intramolecular conjugate addition of it had 
been applied to synthesize stereoselective β-amino-a-hydroxy acids. In the 
previous reports on the stereoselective synthesis of g-amino-β-hydroxy acids, 
an a,β-unsaturated ester group was used as an efficient Michael acceptor of 
the N-hydroxymethyl group (Scheme A2).6-10 Contrast to the previous studies, 
a nitroolefin A15, or a conjugated arylsulfoxide A17 was envisioned for the 
synthesis of one-carbon less Michael acceptor than g-amino-β-hydroxy acids 
(Scheme A11). The nitromethyl group of A16 or the arylsulfinyl group of A18, 
resulted from the intramolecular conjugate addition between the N-
hydroxymethyl group and the introduced internal Michael acceptor, could be 
easily transformed into a carboxylic acid or an aldehyde via the Nef 
reaction,20 or the Pummerer rearrangement,21 respectively. 
Configurationally stable a-amino aldehyde A2 (R = Bn), a starting material 
in Scheme A11, was obtained in two steps from commercially available N-
Boc-L-phenylalanine by following the reported procedure.4 In the beginning, 
the installation of the conjugated phenylsulfinyl group into A2 was tried via 
the Horner-Wadsworth-Emmons olefination with (diethylphosphoryl)methyl-
phenylsulfoxide,22 or via the Peterson olefination with 























































Scheme A11. Synthetic strategy for β-amino-a-hydroxy acids. 
 
 Then, the introduction of another potent Michael acceptor, a nitroolefin 
group, was attempted in order to obtain the nitroolefin A15 in Scheme A11. 
The Henry (nitro-aldol) reaction24 of A2-Ser with nitromethane under 
conventional reaction conditions produced a nitro-aldol adduct without the N-
hydroxymethyl group (A19, Scheme A11) whose instability under either basic 
or acidic conditions had been reported before.4a The reinstallation of the N-
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 To address the elimination issue of the N-hydroxymethyl group, probably 
caused by the basic conditions of the nitro-aldol reaction, we considered more 
reactive nitromethane derivative to produce the desired nitroolefin group in-
situ via the facile dehydration of the initial nitro-aldol intermediate.  
Among the reported activated nitromethanes,25 phenylsulfonylnitromethane 
was well suited to our purpose. Initially, any of the desired nitro-aldol 
products were not produced with a dianion of phenylsulfonylnitromethane, 
prepared by treating phenylsulfonyl-nitromethane with LDA (3 equiv.) at low 
temperature, which was the reported reaction conditions by P. A. Wade et 
al.17b Other bases such as BuLi, KHMDS, K2CO3, or Cs2CO3 did not help. 
Neither did use of a monoanion of phenylsulfonylnitromethane. Only starting 
materials were recovered intact after the reactions. 
When the base was changed to TEA, however, some adduct with a phenyl-
sulfonylnitromethane group was produced in low yield as a diastereomeric 
mixture. Among amine bases tested, such as TEA, DMAP, pyridine, N-
methylmorpholine, and DBU, the highest yield (57%) of the diastereomeric 
adduct was obtained with DMAP. On the 1H NMR spectrum of the adduct, no 
double bond seemed present. A downfield shift of the methine proton at 
around 5.5 ppm was typical for protons at the carbon of 
phenylsulfonylnitromethane, and its coupling pattern of doublet seemed to 











































Scheme A13. β-Amino-a-hydroxy acids synthesis with PhSO2CH2NO2. 
 
 Both structure and stereochemistry of the adduct A22-Ser were established 
after oxidation of the phenylsulfonylnitromethyl group of A22-Ser into the 
carboxylic ester group of A23-Ser at low temperature (-98 to -78 oC),26 where 
A23-Ser was obtained from A22 in 85% yield (Scheme A13). No peaks from 
the minor isomer were seen on both GC and 1H NMR charts of A23-Ser. 
Through the developed prodecure, phenylalaninal derivative (A23-Phe) was 
also synthesized (Scheme A14). Finally, the stereochemistry of A23-Phe was 
confirmed after conversion into a known β-amino-a-hydroxy acid, (2R,3S)-3-
amino-2-hydroxy-4-phenylbutanoic acid (AHPBA) as its HCl salt after global 
deprotection of the protecting groups of A23-Phe under acidic conditions 
(Scheme A14). Its spectral and physical data as well as the optical purity well 



















Scheme A14. The absolute stereochemistry of A23-Phe. 
 
In summary, the application of N-hydroxymethyl group on a stable a-amino 
aldehyde had been expended to synthesize a serious of β-amino-a-hydroxy 
acids. Although the high stereoselectivity had been observed via the 
intramolecular conjugatae addition between the N-hydroxmethyl group and 
the introduced phenylsulfonylnitroolfie, which occured with the addition of 
phenylsulfonyl-nitromethane to the stable aldehyde under basic reaction 
condition, the reaction conditions had to be optimized for better yield. If the 
reaction conditions were optimized and the reaction mechanism was able to 
be verified, the new application of N-hydroxymethyl group in the synthesis of 
β-amino-a-hydroxy acids could be utilized to synthesize biologically active 





Results and Discussions 
 
1. The stereoselective synthesis of threo-β-amino-a-hydroxy acids 
  
The stereoselective synthesis of threo-β-amino-a-hydroxy acids had 
progressed via the intramolecular conjugate addition of the N-hydroxymethyl 
group on stable a-amino aldehydes. High stereoselectivity (>20:1) was 
obtained by the intramolecular conjugate addition of the N-hydroxymethyl 
group. In order to utilize the new stereoselective method to synthesize 
biologically active natural product, the reaction conditions had to be 
optimized.  
 Phenylalaninal A2-Phe was selected as a starting material (Scheme A15), 
contrasted to the initial reaction that was started with serianl derivative A2-
Ser. The condensation reaction between phenylalaninal A2-Phe and the 
activated nitromethane, phenylsulfonylnitromethane (PhSO2CH2NO2), was 
performed in the presence of DMAP with vigorous stirring. However, it was 
hard to purify the intramolecular conjugate adduct A22-Phe from the 
remained starting material due to thier similar polarities. Moreover, the 
conjugate adduct showed the trailing on the silica gel chlromatography. 
Therefore, the optimization on the condensation step was performed to obtain 
full conversion. The higher concentration of the reaction mixture, the more 
increased yield on the condensation step was observed, but the startimg 
material had still remained. The addition of excess amount of 



















































Scheme A15. Stereoselective synthesis of threo-AHPBA.  
 
While the reaction conditions had been optimized, the structures of the 
synthesized compounds were reconfirmed by the functional group 
transformation and NMR studies. In the functional group transformation, the 
stereoselectivity of each compound was measured by 1H NMR or gas 
chromatography. 
The stereoselectivity of A22-Phe was measured right after the one-step 
conversion of phenylsulfonylnitromethyl group to methyl ester via ozonolysis 
at -78 oC in methanolic solution. The trans-oxazolidine methyl ester A23-Phe 
was the sole product, which was confirmed by both 1H NMR study and GC 
analysis. The proposed mechanism of the oxidative Nef reaction of 
phenylsulfonylnitromethane was depicted in Scheme A15. Under the basic 
reaction conditions, the conjugate adduct A22 was converted to 
phenylsulfonylnitronate, and then the followed ozonolysis gave the 


































 Scheme A16. Proposed mechanism of oxidative Nef reaction with A22. 
 
The transformation of phenylsulfonylnitromethyl group on A22-Phe to 
nitromethane A24-Phe was another way to prove the stereoselectivity of A22-
Phe, which was a diastereomeric mixture with approximately 2:1 ratio 
calculated based on 1H NMR spectrum. Even under microwave assisted 
reaction conditions, the minor isomer was not detected both GC and 1H NMR 
charts of A24-Phe. Moreover, much improved yield was obtained in the 
presence of AIBN under the microwave irradiation, instead of the exposure to 
UV lamp which was the original reaction conditions with A22-Ser. The 
following two-step transformation of A24-Phe into A23-Phe via A25-Phe 
also supported the stereoselective formation of A22-Phe.  
The stereochemistry of A23-Phe was assumed as trans-oxazolidine based on 
the previous results on the conjugate addition of the N-hydroxymethyl group 
to the a,β-unsaturated ester group where the trans-oxazolidines were resulted 
from the favored H-eclipsed allylic conformation at the transition state. 6-10, 28 
The NMR coupling constants of the oxazolidine ring of A23-Phe was not 
useful to determine its relative stereochemistry because of the flexible 




confirmed right after the acidic hydrolysis of A23-Phe by the comparing the 
spectral and physical data including the optical purity of the synthesized 
AHPBA with those reported in the literature.  
Figure A4 showed 1H NMR data of A22-Phe that was measured at 40 oC in 
order to make the peaks sharp. Not much of sharpening in the shape was 
observed even at 60 oC. As like the previously mentioned, a-proton of 
phenylsulfonylnitromethane was shown in 5.40~5.49 ppm. Because A22-Phe 
was the diastereomeric mixture, the determination of the peaks from major 
diastereomer was required to verify the structure. At the first step on the 
assignment of the peaks, decoupling studies had been tried to verify the peaks 
of the major diastereomer, but they were not clearly specified due to the 
similar chemical shifts between the two diastereomers.   
 
 




Therefore, the heteronuclear single quantum coherence spectroscopy study 
of A22-Phe had been performed, and the observed spectra were shown in 
Figure A5 and A6. The verification of phenyl peaks from the major 
diastereomer was impossible. The a-protons of the major and minor 
diastereomers were clearly verified and the protons at ③ (shown in figure 
A5) were also verified although the chemical shift of them were quite 
different. However, other peaks, the protons at ② and ④ in figure A5, were 
not able to be determined due to the almost same chemical shifts and flexible 
conformation of the oxazolidine. From the results on HSQC studies and the 
previously mentioned decoupling studies (not shown) the assignment of A22-









































Based on the structural investigation of A22-Phe, it was proposed that the 
desired oxazolidine A22-Phe was produced probably from an intramolecular 
conjugate addition of the N-hydroxymethyl group to the activated nitroolefin 
of A27, which seemed to be generated in turn by facile dehydration of the 
resulting nitro-aldol intermediate A26 (Scheme A17). The possibility of the 
direct cyclization of A26 into A22 was excluded based on the basic reaction 
conditions, under which an SN2 reaction between the N-hydroxymethyl group 





























Scheme A17. Proposed methanism of the intramolecular conjugate addition. 
 
The three tandem reactions from A2-Phe to A22-Phe, i.e., the nitro-aldol, 
the dehydration, and the intramolecular conjugate addition reactions, occurred 
in one-pot (Scheme A17). Other points to note here were that the dehydration 
reaction from A26 to A27 did not require any additives, such as acids or 
leaving groups, and that the separate conjugate addition step from A27 to 
A22-Phe was not required, which was necessary in the previous studies for 




A high stereoselectivity seemed to be achieved in the intramolecular 
conjugate addition of A27 into A22-Phe because only the two isomers out of 
the four possible isomers were notable in 1H NMR spectrum of A22-Phe 
(Figure A4). Absence of the minor cis isomer on both GC and 1H NMR charts 
of A23-Phe suggested that an excellent selectivity (more than 20:1) was 
attained in the intramolecular conjugate addition of the N-hydroxymethyl 
group of A27 to give the trans isomer as nearly one isomer.  
The selectivity for the trans-oxazolidine could be explained based on the 
previous reports about the intramolecular conjugate addition of the N-
hydroxymethyl group to the a,β-unsaturated ester group.6 The much 
improved selectivity in this study may be attributed to the considerably 
favored H-eclipsed conformation at the transition state because of the 
increased allylic (A1,3) strain from the bulkier cis substitutent on 
phenylsulfonylnitroolefin (either SO2Ph or NO2) in the R-eclipsed 
conformation (Scheme A18).28 The similar enhanced selectivity was 
previously observed in the stereoselective synthesis of threo-β-hydroxy-L-
glutamic acid when the stereochemistry of the conjugated ester group was 
































Scheme A18. Proposed transition state for high stereoselectivity. 
 
Efficiency of the transformation process of A2 into A23 could be improved 
further through the in-situ ozonolysis of the diastereomeric adduct A22 
without its isolation. Thus, the trans-oxazolidine methyl ester A23 was 
produced in 72% yield from a-amino aldehyde A2-Phe from the one-pot 
process (Scheme A19), which gave a much higher yield than that of the 







A23-Phe R = Bn (72%); A23-Leu R = i-Bu (69%);
A23-Val R = i-Pr (65%); A23-Ala  R = Me (67%);
























The one-pot process had been also successfully applied to other a-amino 
aldehydes, which were derived from the commercially available a-amino 
acids (Scheme A19). The trans-oxazolidine methyl esters of β-amino-a-
hydroxy acids A23 were obtained in 65% to 79% yields with more than 20:1 
stereoselectivity by following the one-pot procedure. Both structure and 
stereochemistry of A23 were assigned as an analogy to that of A23-Phe. 
 Most of the reaction conditions for other a-amino aldehydes were the same 
as those for the phenylalaninal A2-Phe as described above except for the 
valinal derivative A23-Val, which required higher reaction temperature of 50 
oC instead of room temperature on the condensation with 
phenylsulfonylnitromethane. Interestingly, the valinal A2-Val also showed the 
high stereoselectivity of the trans-oxazolidine, which was a different result 
from the previous studies with the valinal derivative. In the previous study on 
the intramolecular epoxidation with the N-hydroperoxymethyl group, the 
opposite stereoselectivity, syn-epoxide, was observed with valinal derivatives 
due to the A1,3-strain whereas serinal deirvative converted to the 
corresponding anti-epoxide via the favorable N-eclipsed allylic conformation 
from the dipole-dipole repulsion between the peroxy group and the double 
bond. 8     
With leucinal A2-Leu, another well-known threo-β-amino-a-hydroxy acid, 
(2R,3S)-3-amino-2-hydroxy-5-methylhexanoic acid, (2R,3S)-AHMHA, was 
prepared in 88% yield as a HCl salt by acidic hydrolysis of A23-Leu, whose 
spectral and optical data were nearly identical with its enantiomer in the 
literature (Scheme A19).29  




acids and their derivatives had been developed with the N-hydroxymethyl 
protected a-amino aldehydes. Desired β-amino-a-hydroxy acid derivatives 
A23 were produced with high stereoselectivity in a one-pot process from the 
reactions of the a-amino aldehydes and phenylsulfonylnitromethane in the 
presence of an amine base followed by in-situ oxidation. Thus, protected β-
amino-a-hydroxy esters A23 were prepared in 65% to 79% yields with more 
than 20:1 stereoselectivity in one reaction flask. Both absolute and relative 
configuration of A23-Phe and A23-Leu were established beyond doubt after 
one-step acidic hydrolysis into the known β-amino-a-hydroxy acids, (2R,3S)-
AHPBA and (2R,3S)-AHMHA as their HCl salts, respectively. A probable 
reaction mechanism for the three tandem reactions, i.e., the nitro-aldol, the 
dehydration, and the intramolecular conjugate addition reactions, was 
proposed to rationalize the reaction results. 
 Based on the well-developed stereoselective synthetic method for β-amino-
a-hydroxy acid, some biologically active natural products had been 




2. Application of the stereoselective synthetic method  
for β-amino-a-hydroxy acids : bestatin and its derivatives 
 
 Bestatin, also known as ubenimex, had been explored as a potent peptidase 
inhibitor, especially as an aminopeptidase N (APN) inhibitor. Generally, APN 
releases N-terminus neutral amino acids from oligopeptide or protein via the 
activated hydrolysis of the peptide bond by the coordination with Zn2+ on the 
active site of aminopeptidase N.11 The effects of APN on the protein activation, 
degradation, and regulation were related with the inflammatory diseases and 
tumors. For this reason, APN inhibitor had been studied for therapeutic means. 
Among the known APN inhibitors, bestatin showed multiple effects on the 
immune system with low toxicity.30 Its structure was known as a dipeptide of 
the unnatural vicinal amino hydroxy acid at the N-terminus and the natural 








Figure A7. The structure of bestatin. 
 
The interaction between bestatin and the Zn2+ embedded at the active site of 
aminopeptidase was completed by the participation of its free amino, hydroxy 



















Figure A8. The interaction between bestatin and the active site of APN. 
 
Based on the diverse effects of bestatin on immune system, various synthetic 
methods had been reported for the stereoselective synthesis of bestatin,32 and 
diverse analogs from epibestatin to leucine residue replacements had been 
synthesized and studied to identify thier bioactivities. However, not many of 
studies had been done on the N-terminus residue modification.  
 According to the recent report on the human aminopeptidase N (hAPN), the 
carboxylic acid at C-terminus of bestatin interacted with Zn2+ at the active site 
of hAPN, and other functional groups, amino, hydroxy and the carbonyl group 
at the peptide bond, made hydrogen bonds with the glutamine at the active site 
(Fig. A9). Dissimilar to the interaction of bestatin, β-amino-a-hydroxy acid 
unit on amastatin interacted with Zn2+ on hAPN (Fig. A10). The different 
intereactions on hAPN may be caused by the side chains on the 
aminopeptidase inhibitors. In other words, the benzyl group on bestatin 
formed a π-π interaction with the phenylalanine at hAPN, which made a 








































As the first application of the developed stereoselective synthetic method 
for threo-β-amino-a-hydroxy acids, the synthesis of bestatin had been planed 
(Scheme 19). Because the intramolecular conjugate addition of the N-
hydroxymethyl group could be applied to the various amino acids, new 
bestatin analogs containing alkyl groups instead of benzyl group at the N-
terminus was also planed to be synthesized with the stereoselective 












































Scheme 20. Retrosynthesis of bestatin. 
 
The synthesis of bestatin was started with the preparation of the suitable 
starting material, enantiomer of A2-Phe. From commercially available N-
Boc-D-phenylalanine, the stable a-amino aldehyde had been synthesized via 
the same procedure of the previously reported paper (Scheme 21),8 and the 
stable a-amino aldehyde had been converted to the corresponding 
stereoselective methyl ester ent-A23-Phe according to the one-pot protocol as 




























Scheme A21. Preparation of the starting material for bestatin synthesis. 
 
A simple peptide coupling of free carboxylic acid (not shown), which 
produced from the basic hydrolysis of ent-A23-Phe, with L-leucine methyl 
ester (L-Leu-OMe) afforded peptide A28-Phe, and then the followed basic 
and acidic hydrolysis gave bestatin as its TFA salt (Scheme 22). Finally, a 
known dipeptide bestatin was obtained in high yield (92%) without the 
separate protection and/or deprotection steps for the vicinal amino hydroxy 
acids moiety. The spectral and physical data of the synthesized bestatin were 
































Scheme 22. Synthesis of bestatin. 
 
One of the bestatin analogs,2 AHPBA-Val, was also synthesized by 
following the same synthetic process (Scheme A22), which was reported to be 
a more potent aminopeptidase inhibitor than bestatin.33  
 Based on the successful synthesis of betatin and AHPBA-Val, bestatin 




the same procedure. One of the synthesized bestatin analogs was started with 
N-Boc protected D-leucine, while the other analog was synthesized with N-
Boc protected D-valine. Each of the a-amino aldehyde, lactol, was converted 
to the stereoselective methyl ester ent-A23-Leu or ent-A23-Val in 63% or 
49% yield, respectively. Unfortunately, the yield of ent-A23-Val had not 
increased even in extended reaction time at 40 or 50 oC. In the peptide bond 
synthesis, isobutyl chloroformate was applied at first, the desired peptide was 
synthesized in less than 50% yield. In order to optimize the reaction 
conditions, the coupling reagent was changed to N-(3-dimethylaminopropyl)-
N’-ethylcarbonate (EDC), and the desired peptides had been synthesized in 
better yield (74%) in the presence of HOBt (Scheme A23).   
 
PhSO2CH2NO2;




















R=i-Bu,  ent-A23-Leu (63%)
R=i-Pr,  ent-A23-Val (49%)
R=i-Bu, A28-Leu (74%)



















Scheme A23. Synthesis of betatin anlogus, A29 and A30. 
 
 During the previous synthesis of bestatin and AHPBA-Val, the final 




reaction conditions on the acidic hydrolysis for the deprotection of N-Boc 
group and N,O acetal cleavage had been changed. The desired bestatin 
analogs had been produced without impurities via the simple extraction with 
water and ethyl acetate (EtOAc) after the acidic hydrolysis in methylene 











































Figure A11. The stereoselectively synthesized dipeptides. 
 
In summary, the well-known aminopeptidase inhibitor, bestatin, which was 
also known as Ubenimex, had been synthesized from the trans-oxazoldine 
methyl ester (ent-A23-Phe). Because the applied oxazolidine was a protected 
form of the vicinal amino alcohol, the protection (or deprotection) of the 
functional groups was not required. Moreoever, its analogs were 
stereoselectively synthesized from N-Boc-D-amino acids effectively via the 
well-developed procedures. Among the synthesized analogs, A29 and A30 




3. Application of the stereoselective synthetic method  
for β-amino-a-hydroxy acids : threo-β-benzyloxyaspartate 
  
L-Glutamate is the major excitatory neurotransmitter in the mammalian 
central nervous system, and its action is thought to be linked to higher brain 
functions, such as memory and learning. However, the extracellular 
concentration of it is strictly controlled at ~1 µM because glutamate is also 
known as a potent excitotoxin that causes neuronal degeneration.2 The control 
of the concentration is performed by glutamate transporters. Although their 
important roles have been elucidated by genetic approaches, genetic 
manipulations cannot provide any information on the dynamics of glutamate 
homeostasis in response to the acute disruption of uptake systems. Therefore, 
pharmacological intervention with selective blockers is an essential approach 
to investigate the physiological roles of the transporters.  
Many glutamate analogs had been screened as uptake inhibitors, and they 
had been important tools to address the function of glutamate transporters.34 
In addition, conformationally constrained analogs had provided useful 
pharmacophore models, but most of these inhibitors acted as competitive 
substrates, which were transported. Although such competitive substrates 
reduced glutamate uptake, they induced ion flux or heteroexchange, which 
was the exchange of external substrate with internal substrate. Therefore, non-
transportable blockers that did not affect glutamate recepter were 
indispensable for elucidating the function of the glutamate transporters.    
Sometimes a substrate for the glutamate transporters was converted to a 




transporters, 35 but it was converted as a blocker by introducing substituents at 
the β-position. The introduced β-hydroxy group may decrease both 
transportability through transporters and affinity toward glutamate receptors 
(Figure A10).12   
 
Figure A12. The conversion of L-Asp as the glutamate blocker. 
 
While glutamate uptake was inhibited by O-acetylated THA,35 O-benzoyl 
analog did not only inhibit the uptake but also decreased the glutamate 
induced current. Due to the unstability of O-acyl analogs, however, ether-type 
analogs were synthesized. Among the ether-type analogs, L-threo-β-
benzyloxyaspartate (L-TBOA), a specific extracellular amino acid transporter 
(EAAT) antagonist,38 showed the inhibitory activity against glutamate 
transporters.39 Therfore, the syntheses of L-threo-β-benzyloxy aspartate and 












































Scheme A24. The previous synthetic route for L-TBOA. 
 
In the previous synthesis of L-TBOA, the corresponding vicinal amino 
alcohol had been synthesized in moderate stereoselectivity (threo:erythro = 
6:1) via the addition of vinyl zinc chloride to (R)-Garner aldehyde (Scheme 
A23). The moderate stereoselectivity and efficiency on the synthesis of L-
TBOA was attractive because those could be improved via the intramolecular 
conjugate addition of the N-hydroxymethyl group. The scheme A25 depicts 














































At the beginning on the synthesis of L-TBOA, the suitable amino acid was 
selected as D-Ser-OH, which possesses hydroxymethyl side chain. The side 
chin could be readily converted to methyl ester moiety by the reported 
procedures including deproteaction, the oxidation and the following 
methylation.10 Therefore, the stable a-amino aldehyde (ent-A2-Ser) with N-

























Boc-D-Ser-OH ent-A2-Ser  
Scheme A26. The preparation of the stable serinal derivative. 
 
The same one-pot procedure (Scheme A19) was applied for the highly 
stereoselective synthesis of ent-A23-Ser (Scheme A26). The desired trans-
oxazolidine methyl ester ent-A23-Ser was produced in 69% yield with more 
than 20:1 stereoselectivity in one reaction vessel, where the tandem three 
reactions occurred between the serianl derivative ent-A2-Ser and the activated 
nitromethane PhSO2CH2NO2. The high stereoselectivity was presented by the 
intramolecular conjugate addition between the N-hydroxymethyl group and 
the temporarily generated phenylsulfonyl nitroolefin.  
With the trans-oxazolidine methyl ester ent-A23-Ser, the transformation of 
hydroxymethyl group was performed to synthesize trans-oxazolidine 
dimethyl ester A31. First, the silyl protecting group was removed with TBAF, 




After the reaction with TMS diazomethane, acidic hydrolysis with excess 
amount of TFA in CH2Cl2 solution accompanined (2S, 3S)-dimethyl-2-amino-
3-hydroxysuccinate (not shown). The impurities from the acidic hydroxlysis 
were removed by the simple extraction with water and ethylene acetate. In 
order to obtaine the N-Boc-protected form of dimethyl-2-amino-3-
hydroxysuccinate, several reaction conditions with some reagents including 
oxalic acid were applied to cleavage of the N, O acetal, but the desired 
product was not obtained. Unfortunately, the previously reported oxidation of 
the N, O acetal with RuCl37,10 did not present the corresponding product (not 
shown). Therefore, the acidic hydrolysis with TFA and N-Boc protection were 
schemed although the efficiency of the synthesis was impared by the 
additional protection step. 
TFA, rt.;
Boc2O, Na2CO3
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Scheme A27. The stereoselective synthesis of L-TBOA. 
 
Before the introduction of benzyl group to β-hydroxy group on A32, the free 
amino group was protected with Boc. In the protection, hydrolyzed carboxylic 
acid was obtained with NaHCO3 and Boc2O under the ambient atmosphere. 




at room temperature, Boc protection was arisen at both amino and hydroxyl 
groups. Due to the formation of the di-Boc protected compound (not shown), 
the yield on the Boc protection was obtained in below 50%.  
With the desired N-Boc protected dimethyl succinate A32, the protection of 
the hydroxyl group with benzyl bromide was performed under the basic 
reaction conditions. After the following sequential basic and acidic hydrolysis, 
the desired threo-β-benzyloxy aspartic acid was synthesized with high 
stereoselectivity.    
The stereochemistry was verified via the formation of L-threo-β-hydroxy 
aspartic acid by the acidic hydrolysis of ent-A32-Ser (Scheme A28). The 
measured optical rotation on the prepared L-threo-β-hydroxy aspartic acid 
was shown in scheme A28 with the previously reported value, which was 




















obs. [a]D = -7.3 (c 1.32, 5 N HCl)
  lit.   [a]D = +7.5 (c 1, 5 N HCl)
    for D-threo-β-hydroxyaspartic acid
ent-A2-Ser ent-A32-Ser L-threo-β-hydroxyaspartic acid
Scheme A28. The stereochemistry of ent-A32-Ser. 
 
    Finally, the stereoselective synthesis of L-threo-β-benzyoxyaspartic acid, 
another application of the stereoselective synthetic method for β-amino-a-
hydroxy acids with the N-hydroxymethyl group, was completed via the 




generated phenylsulfonylnitromethane.  The successful development of the 
stereoselective route for L-TBOA would be contributed to the elucidation on 
the function of glutamate transporters through the facile derivatization of L-




4. Application of the stereoselective synthetic method  
for β-amino-a-hydroxy acids : lapstatin and its derivatives 
 
 Streptomyces species have been used as a source of low-molecular-weight 
enzyme inibitors, and well-known aminopeptidase inhibitor bestatin, 
amastatin and AHPBA-Val are come from these species. Besides theses three 
aminopeptidases, phebestin and actinonin are also originated from 



























from Streptomyces sp. ME98-M3
bestatin (R = i-Bu)
 from Streptomyces oliverticuli  
AHPBA-Val (R = i-Pr)





















Figure A13. Aminopeptidase inhibitors from Streptomyces. 
 
Since a leucine aminopeptidase was isolated from the waste broth of 
oxytetracycline production by Streptomyces rimosus, it was found that the 
leucine aminopeptidase was inhibited by bestatin and amastatin. Based on the 
previous studies on Streptomyces rimosus, it was curious that the culture 
medium of S. rimosus contained a low-molecular-weight inhibitor. Through 




aminopeptidase had been reported. The new aminopeptidase had been named 
as lapstatin. Although the structure of it had been reported by Lampret et al in 
1999,42 the stereochemistry had not been verified yet (Figure A14). According 
to the report, lapstatin contained nautral amino acid valine and unnatural 
amino acid, 3-amino-2-hydroxy-4-methylpentanoic acid (AHMPA). The 




















unnatural amino acid natural amino acid
 
Figure A14. Structure of lapstatin.41 
 
As like previously mentioned, the stereoselective intramolecular conjugate 
addition of the N-hydroxymethyl group could be started with various amino 
acids including phenylalanine, leucine and serine. The unnatural amino acid, 
AHMPA, could be synthesized from L-valine or D-valine. Therefore, the 
synthesis of lapstatin was planed to verify the stereochemistry of 3-amino-2-
hydroxy-4-methylpentanoic acid (AHMPA) via the stereoselective 

















































Scheme A29. Retrosynthesis of lapstatin from D-Valine. 
 
The synthetic plan for lapstatin is similar to the synthesis of bestatin 
derivatives (Scheme A22). At first, two stable a-amino aldehydes A2-Val 
were prepared from Boc-D-Val-OH, and Boc-L-Val-OH, and then the reaction 
with phenylsulfonylnitromethane was performed with each of the valinal 
derivatives (A2-Val or ent-A2-Val). Unfortunately, the full conversion of the 
valinal derivatives had not observed during the optimization of the reaction 
conditions, such as reaction temperature, solvent, or the concentration of the 
reaction mixture, and the disappointable results might be cuase by the higher 
stability of the valinal derivatives than the other derivatives. Although the 
reaction condition had not been optimized, the rest of the synthesis was 
















































Scheme A30. Synthesis of lapstatin from Boc-D-Val-OH. 
 
The in-situ oxidative Nef reaction via ozononlysis with the conjugate 
adducts A22-Val afforded the stereoselective intermediate trans-oxazolidine 
methyl esters A23-Val. The following basic hydrolysis and peptide coupling 
with L-Val-OtBu produced two diastereomers. The desired dipeptides were 
finally obtained by the acidic hydrolysis with TFA. Figure A15 showed the 
synthesized dipeptides which containing threo-AHMPA at N-terminus and L-



















Figure A15. The prepared dipepdes A35 and A36. 
 
 1H NMR spectra of A35 was almost identical with the reported data.42 




AHMPA because of the lack of other analytical informations, such as optical 
rotation, from the previous report. Therefore, the synthesis of erythro-
AHMPA had been tried. There was a report on the stereodivergent synthesis 


























cis (dr  > 99:1)
trans (dr  > 99:1) (2R,3S)-AHMPA
(2S,3S)-AHMPA
Scheme A31. Stereodivergent synthesis of β-amino-a-hydroxy acids. 
 
 In order to take the reported diasteroselective epimerization, oxazolidinone 
synthesis had been tried with protected serine or leucinal nitro aldol product 




































































Another attempt to prepare the oxazolidinone was the oxidation of the 
oxazoline with ruthenium catalyst. In the previous study on the divergent 
synthesis of g-amino-β-hydroxy acids, the mixture of oxazolidone and O-
formylated compound was obtained under the oxidation reaction conditions 
with RuCl3 and tBuOOH. Unfortunately, the desired product was not obtained 
with A23-Val. It was assumed that high stability of the valine derivative may 
cause the disappointed result. However, the desired oxazolidinone had not 

























NO2 NO2A24-Leu  
Scheme A33. Ruthenium catalyzed oxidation with A23-Val and A24-Leu. 
 
Based on the disappointed results on the preparation of oxazolidinone, the 
epimerization of the oxazolidine A23-Val had been tried, and the possibility 





















A37 A38  





The verification and optimization of the products from the epimerization 
with A23-Val might allow the synthesis of erythro-AHMPA. The studies on 
the synthesis of erythro-AHMPA had been progressed on our lab. The 
following two dipeptides containing erythro-AHMPA will be significant 
evidences to support the determined stereochemistry of lapstatin by 
comparing the reported NMR spectrum with that of the synthesized dipeptides 


















A39 A40  
Figure A16. The prepared dipeptides with erythro-AHMPA. 
 
 As like mentioned at the beginning of this section, this was the first attempt 
of the verification of stereochemistry on lapstatin, which was known as low-
molecular-weight enzyme inibitors. The verification of the stereochemistry 
and the development of divergent synthesis of β-amino-a-hydroxy acid would 
be used for the preparation of diverse aminopeptidase inhibitors, which had 
been used for the biochemical characterization of aminopeptidases and for 








It had been developed that a novel and efficient synthetic method for β-
amino-a-hydroxy acids and their derivatives from the N-hydroxymethyl 
protected a-amino aldehydes. Desired β-amino-a-hydroxy acid derivatives 
A23 were produced with high stereoselectivity in a one-pot process from the 
reactions of a-amino aldehydes with the N-hydroxymethyl group and 
phenylsulfonylnitromethane in the presence of an amine base followed by in-
situ oxidation. From the developed stereoselective intramolecular conjugate 
addition, several bioacitive compounds including bestatin and L-TBOA had 
been synthesized. Moreover, the verification of stereochemistry of lapstatin 








General Procedure. Materials were obtained from commercial suppliers and 
were used without further purification. Methylene chloride was distilled from 
calcium hydride immediately prior to use. Air or moisture sensitive reactions 
were conducted under nitrogen atmosphere using oven-dried glassware and 
standard syringe/septa techniques. The reactions were monitored with a SiO2 
TLC plate under UV light (254 nm) and by visualization with a ninhydrin 
staining solution. A CEM Discover SP microwave unit was used for 
microwave reactions. In the microwave reactions, reaction temperature and 
pressure were monitored by the provided monitoring software. Column 
chromatography was performed on silica gel 60 (70-230 mesh). Optical 
rotations were determined at ambient temperature with a digital polarimeter 
and are the average of ten measurements. 1H and 13C NMR spectra were 
measured at 400 MHz and 100 MHz, respectively in CDCl3 unless stated 
otherwise. The 1H NMR spectral data were reported as follows in ppm (δ) 
from the internal standard (TMS, 0.0 ppm): chemical shift (multiplicity, 
integration, coupling constant in Hz). The 13C NMR spectra were referenced 
with the 77.16 resonance of CDCl3, 39.51 resonance of DMSO-d6, or 49.00 
resonance of MeOH-d4. Gas chromatographic analyses were done with a 
capillary column (30 m × 0.25 mm). Infrared spectra were obtained as a film 
on a SiO2 wafer. Low and high resolution mass spectra were measured by the 
CI ionization method and analyzed by magnetic sector mass analyzer. 




To a-amino aldehyde A2-Phe (R = Bn, 230 mg, 0.82 mmol) in THF (1 mL) 
was added phenylsulfonylnitromethane (199 mg, 0.90 mmol) and DMAP (151 
mg, 1.24 mmol). The mixture was stirred at room temperature for 2 days until 
the starting material A2-Phe disappeared. The reaction mixture was diluted 
with EtOAc (5 mL), to which was added an aqueous saturated solution of 
NH4Cl (20 mL). The resulting mixture was separated and the aqueous layer 
was extracted with EtOAc (20 mL  3). The combined organic layers were 
dried over MgSO4, filtered, and concentrated under reduced pressure. The 
organic residue was purified by silica gel chromatography (hexane:EtOAc = 




carboxylate; 57% (281 mg); colorless oil; The major isomer of A22-Phe: 1H 
NMR (600 MHz, 40 oC) δ 1.44 (s, 9H), 2.89 (dd, 1H, J = 7.2, 13.5), 3.07 (br s, 
1H), 4.66 (d, 1H, J = 9.3), 4.70 (br s, 1H), 4.82 (t, 1H, J = 7.2), 5.03 (br s, 1H), 
5.40 (d, 1H, J = 9.3, HC(NO2)SO2Ph), 7.05-7.93 (m, 10H); 13C NMR δ 28.3, 
37.9, 59.1, 78.3, 78.8, 81.7, 101.2 (HC(NO2)SO2Ph), 127.2-136.3 (the peaks 
of the aryl carbons), 152.1; IR (film): 1345, 1399, 1566, 1703 cm-1; HRMS 
(CI) calcd for C22H27N2O7S 463.1539 ([M+H]+), found 463.1541. 
A22-Leu  
tert-Butyl (4S,5R)-4-isobutyl-5-((phenylsulfonyl)nitromethyl)oxazolidine-3-
carboxylate; 67% (607 mg); colorless oil; The major isomer of A22-Leu: 1H 
NMR (600 MHz, 40 oC) δ 1.02 (d, 3H, J = 6.6), 1.05 (d, 3H, J = 6.6), 1.47-




1H, J = 4.2), 4.75 (t, 1H, J = 7.2), 5.13 (br s, 1H), 5.36 (d, 1H, J = 9.6, 
HC(NO2)SO2Ph), 7.61-8.00 (m, 5H); 13C NMR δ 22.7, 25.0, 28.4, 41.7, 56.4, 
77.9, 78.3, 81.7, 101.3 (HC(NO2)SO2Ph), 129.6-136.1 (the peaks of the aryl 
carbons), 152.9; IR (film): 1345, 1399, 1566, 1706 cm-1; HRMS (CI) calcd for 
C19H29N2O7S 429.1695 ([M+H]+), found 429.1696. 
Oxidation procedure of A22-Phe for methyl ester A23-Phe 
To a diastereomeric mixture A22-Phe (220 mg, 0.48 mmol) in THF (3 mL) 
was added methanol (3 mL) and DBU (0.22 mL, 1.43 mmol) at room 
temperature. The reaction mixture was cooled to -78 oC and ozone was 
bubbled through over 30 min. After the starting material disappeared, the 
reaction mixture was quenched with acetic acid. The organic solvents were 
removed under reduced pressure after the reaction mixture was warmed up to 
room temperature. Then the resulting residue was partitioned between EtOAc 
(20 mL) and an aqueous saturated solution of NH4Cl (20 mL). The aqueous 
layer was extracted with EtOAc (20 mL  2), and the combined organic 
layers were dried over MgSO4, filtered and concentrated under reduced 
pressure. The organic residue was purified by silica gel chromatography 
(hexane:EtOAc = 8:1) to afford the desired ester A23-Phe. 
A23-Phe 
3-tert-Butyl 5-methyl (4S,5R)-4-benzyloxazolidine-3,5-dicarboxylate; 85% 
(130 mg); [α]13D  E = -25.6 (c = 0.76, CHCl3); 1H NMR (50 oC) δ 1.44 (s, 9H), 
2.88 (dd, 1H, J = 8.0, 13.4), 3.07 (br d, 1H, J = 13.4), 3.68 (s, 3H), 4.37 (br s, 
1H), 4.40 (s, 1H), 4.73 (s, 1H), 5.19 (br s, 1H), 7.19-7.30 (m, 5H); 13C NMR δ 
28.4, 38.5, 52.4, 60.1, 78.5, 79.5, 80.9, 126.9, 128.7, 129.6, 136.9, 152.5, 




322.1654 ([M+H]+), found 322.1654. 
General one-pot procedure for methyl ester A23-Phe from A2-Phe 
To a-amino aldehyde A2-Phe (R = Bn, 82 mg, 0.29 mmol) in THF (0.2 mL) 
was added phenylsulfonylnitromethane (65 mg, 0.32 mmol) and DMAP (54 
mg, 0.44 mmol). The reaction mixture was stirred at room temperature for 2 
days with vigorous stirring until the starting material A2-Phe disappeared. 
The mixture was diluted with THF (3 mL) and methanol (3 mL), to which 
was added DBU (0.13 mL, 0.88 mmol) at room temperature. Then, the 
reaction mixture was cooled to -78 oC, and ozone was bubbled through over 
30 min. After quenching the reaction with acetic acid (less than 1 mL), the 
resulting mixture was warmed up to room temperature. After removing the 
solvent under reduced pressure, the residue was partitioned between EtOAc 
(10 mL) and an aqueous saturated solution of NH4Cl (20 mL). The aqueous 
layer was extracted with EtOAc (20 mL  3), and the combined organic 
layers were dried over MgSO4, filtered, and concentrated under reduced 
pressure. The organic residue was purified by silica gel chromatography 
(hexane:EtOAc = 8:1) to afford the desired ester A23-Phe (61 mg, 0.21 mmol, 
72%) as a colorless oil. 
A23-Leu 
3-tert-Butyl 5-methyl (4S,5R)-4-isobutyloxazoline-3,5-dicarboxylate; 69% 
(54 mg); colorless oil; [α]16D  E= -6.7 (c = 0.34, CHCl3); 1H NMR (50 oC)  δ 0.99 
(d, 3H, J = 6.8), 1.01 (d, 3H, J = 6.4), 1.43-1.48 (m, 1H), 1.48 (s, 9H), 1.58-
1.65 (m, 1H), 1.68-1.73 (m, 1H), 3.77 (s, 3H), 4.24 (t, 1H, J = 6.6), 4.34 (s, 
1H), 4.82 (d, 1H, J = 3.6), 5.28 (d, 1H, J = 3.6); 13C NMR δ 22.2, 23.0, 25.3, 




1755 cm-1; HRMS (CI) calcd for C14H26NO5 288.1811 ([M+H]+), found 
288.1808. 
A23-Val 
tert-Butyl 5-methyl (4S,5R)-4-isopropyloxazolidine-3,5-dicarboxylate; 65% 
(109 mg), colorless oil; [α]17D  E = -10.7 (c = 1.17, CHCl3); 1H NMR (50 oC) δ 
0.89 (d, 3H, J = 6.4), 0.90 (d, 3H, J = 6.4), 1.39 (s, 9H), 1.89-1.98 (m, 1H), 
3.67 (s, 3H), 3.89 (d, 1H, J = 5.2), 4.36 (s, 1H), 4.72 (d, 1H, J = 3.2), 5.19 (br 
s, 1H); 13C NMR δ 18.0, 18.8, 28.3, 31.0, 52.3, 64.6, 76.8, 80.0, 80.6, 153.3, 
171.8; IR (film): 1173, 1711, 1757 cm-1; HRMS (CI) calcd for C13H24NO5 
274.1654 ([M+H]+), found 274.1658. 
A23-Leu 
3-tert-Butyl 5-methyl (4S,5R)-4-methyloxazolidine-3,5-dicarboxylate; 67% 
(81 mg), colorless oil; [α]15D   = -5.9  (c = 0.44, CHCl3); 1H NMR (50 oC) δ 
1.37 (d, 3H, J = 6.4), 1.46 (s, 9H), 3.77 (s, 3H), 4.14 (br s, 1H), 4.24 (d, 1H, J 
= 3.2), 4.84 (d, 1H, J = 3.8), 5.20 (d, 1H, J = 3.8); 13C NMR δ 19.3, 28.5, 52.6, 
55.0, 79.2, 80.8, 81.9, 152.6, 170.9; IR (film): 1175, 1707, 1756 cm-1; HRMS 
(CI) calcd for C11H20NO5 246.1341 ([M+H]+), found 246.1345. 
A23-Ser 
3-tert-Butyl 5-methyl (4S,5R)-4-((tert-
butyldimethylsilyloxy)methyl)oxazolidine-3,5-dicarboxylate; 79% (93 mg), 
colorless oil; [α]15D  E = -10.5 (c = 0.71, CHCl3); 1H NMR (50 oC) δ 0.06 (s, 3H), 
0.07 (s, 3H), 0.90 (s, 9H), 1.46 (s, 9H), 3.72-3.81 (m, 2H), 3.77 (s, 3H), 4.07 
(br s, 1H), 4.71 (d, 1H, J = 3.6), 4.79 (d, 1H, J = 3.2), 5.19 (br s, 1H); 13C 
NMR δ -5.3, 18.2, 25.9, 28.5, 52.5, 60.2, 61.7, 77.9, 80.1, 80.9, 152.5, 171.3; 




376.2155 ([M+H]+), found 376.2159. 
Stepwise procedure for methyl ester A23 
General procedure for nitromethyloxazolidine A24-Phe or A24-Leu 
 To conjugate adduct A2-Phe (R = Bn, 67 mg, 0.15 mmol) in toluene (2 mL) 
was added N-benzylnicotinamide (BNAH, 93 mg, 0.44 mmol) and AIBN (5 
mg, 0.03 mmol). The reaction mixture was reacted at 60 oC for 1 h in a 
microwave (MW) reactor (15 W). Then, the mixture was diluted with EtOAc 
(2 mL), to which was added H2O (5 mL). The organic layer was separated and 
the aqueous layer was extracted with EtOAc (10 mL 3). The combined 
organic layers were dried over MgSO4, filtered and concentrated under 
reduced pressure. The organic residue was purified by silica gel 
chromatography (hexane:EtOAc = 8:1) to afford nitromethyloxazolidine A24-
Phe.  
A24-Phe 
tert-Butyl (4S,5R)-4-benzyl-5-(nitromethyl)oxazolidine-3-carboxylate; 62% 
(29 mg); colorless oil; [α]15D  E = -5.7 (c = 2.53, CHCl3); 1H NMR (50 oC) δ 1.51 
(s, 9H), 2.82 (dd, 1H, J = 9.2, 12.0), 3.26 (br d, 1H, J = 12.0), 3.95-4.01 (m, 
2H), 4.32 (dd, 1H, J = 8.4, 12.8), 4.58-4.63 (m, 1H), 4.69 (d, 1H, J = 4.0), 
5.17 (br s, 1H), 7.23-7.37 (m, 5H); 13C NMR δ 28.4, 38.7, 59.2, 76.5, 78.6, 
78.8, 81.4, 127.4, 129.1, 129.4, 136.4, 152.8; IR (film): 1370, 1557, 1679 cm-
1; HRMS (CI) calcd for C16H23N2O5 323.1607 ([M+H]+), found 323.1611. 
A24-Leu 
tert-Butyl (4S,5R)-4-isobutyl-5-(nitromethyl)oxazolidine-3-carboxylate; 72% 
(50 mg); colorless oil; [α]14D  E = -8.2 (c = 0.26, CHCl3); 1H NMR (50 oC) δ 0.98 




1.71 (m, 2H), 3.98 (t, 1H, J = 6.4), 4.39-4.51 (m, 3H), 4.74 (d, 1H, J = 4.8), 
5.20 (d, 1H, J = 4.8); 13C NMR δ 22.5, 23.0, 25.2, 28.5, 42.2, 56.9, 76.8, 78.2, 
79.1, 81.3, 153.2; IR (film): 1372, 1559, 1704 cm-1; HRMS (CI) calcd for 
C13H25N2O5 289.1763 ([M+H]+), found 289.1760. 
Two-step procedure for A23-Phe from A24-Phe 
Nitromethyloxazolidine A24-Phe (R = Bn, 73 mg, 0.23 mmol) in t-BuOH (2 
mL) was stirred in an aqueous solution of 0.5 M KOH buffered with 1.25 M 
of K2HPO4 (1.5 mL) at room temperature for 5 min. To the reaction mixture 
an aqueous solution of 0.5 M KMnO4 (0.90 mL) was slowly added at 0 oC and 
it was stirred at room temperature for 1 h. The reaction was quenched with an 
aqueous saturated solution of Na2SO3 (5 mL) at 0 oC, and the reaction mixture 
was acidified with an aqueous solution of 1 M HCl (6 mL). The resulting 
mixture was separated, and the aqueous layer was extracted with EtOAc (10 
mL 3). The combined organic layers were dried over MgSO4, filtered and 
concentrated under reduced pressure to afford the corresponding acid 
intermediate A25-Phe. To crude acid A25-Phe in DMF (2 mL) was added 
K2CO3 (94 mg, 0.68 mmol) and MeI (0.03 mL, 0.45 mmol). After 1 h at room 
temperature, the mixture was poured into cold water (10 mL). The resulting 
mixture was extracted with diethyl ether (10 mL  3). The combined organic 
layers were dried over MgSO4, filtered and concentrated under reduced 
pressure. The organic residue was purified by silica gel chromatography 
(hexane:EtOAc = 8:1) to afford the desired ester A23-Phe (51 mg, 70%) as a 
colorless oil.  
General procedure for β-amino-a-hydroxy acids, AHPBA.HCl or 




Methyl ester A23-Phe (R = Bn, 152 mg, 0.47 mmol) in an aqueous solution of 
3 M HCl (8 mL) was heated at 80 oC for 8 h. After cooling back to room 
temperature, the resulting mixture was washed with CH2Cl2 (20 mL  2) and 
EtOAc (20 mL  2). The aqueous layer was concentrated under reduced 
pressure to give AHPBA.HCl salt. 
AHPBA.HCl  
(2R,3S)-3-Amino-2-hydroxy-4-phenylbutanoic acid hydrochloride; 92% (85 
mg); white solid; mp. 206-208 oC (lit27a; 209-210 oC); [α]26D  E = -28.8 (c 1.68, 1 
M HCl); (lit.27b [a]D = +29.3 (c 0.43, 1 M HCl); 1H NMR (DMSO-d6) δ 2.88 
(dd, 1H, J = 9.6, 13.4), 3.03 (dd, 1H, J = 5.2, 13.4), 3.58-3.60 (m, 1H), 3.89 (d, 
1H, J = 2.4), 7.27-7.36 (m, 5H), 8.18 (br s, 1H); 13C NMR δ 35.1, 53.9, 67.4, 
126.9, 128.6, 129.3, 136.2, 172.7; IR (film); 1072, 1730, 2931 3040 cm-1; 
HRMS (CI) calcd for C10H14NO3 196.0974 ([M+H]+), found 196.0971. 
AHMHA.HCl 
(2R,3S)-3-Amino-2-hydroxy-5-methylhexanoic acid hydrochloride; 88% (93 
mg); white solid; mp. 208-210 oC (lit.29a 188-189 oC, lit.29b 228-229 oC) 1H 
NMR (MeOH-d4) δ 0.98 (d, 3H, J = 6.4), 1.00 (d, 3H, J = 6.4), 1.47-1.54 (m, 
1H), 1.64-1.79 (m, 2H), 3.56 (dt, 1H, J = 3.2, 7.0), 4.23 (d, 1H, J = 3.2); 13C 
NMR δ 22.5, 22.7, 25.4, 39.8, 52.8, 70.4, 174.4; IR (film): 1101, 1657, 2960, 
3367 cm-1; HRMS (CI) calcd for C7H16NO3 162.1130 ([M+H]+), found 
162.1131. The free amino acid form of (2R,3S)-AHMHA was obtained in a 
quantitative yield by treating (2R,3S)-AHMHA.HCl with a Dowex resin 




Peptide synthesis from methyl ester ent-A23-Phe 
 Preparation of ent-A25-Phe 
To methyl ester ent-A23-Phe (R = Bn, 283 mg, 0.88 mmol) in THF (2 mL) 
was added an aqueous solution of 2 M NaOH (6 mL), and the reaction 
mixture was stirred at room temperature over 2 h. After the reaction mixture 
was diluted with EtOAc (10 mL), the pH was adjusted to ca. 1 with an 
aqueous solution of 1 M HCl. The aqueous phase was extracted with EtOAc 
(20 mL  2). The combined organic layers were dried over MgSO4, filtered, 
and concentrated under reduced pressure to afford the corresponding acid ent-
A25-Phe 
ent-A25-Phe 
3-(tert-Butoxycarbonyl)-(4R,5S)-4-benzyloxazolidine-5-carboxylic acid; 92% 
(249 mg); [α]14D  E = +17.0 (c = 0.92, CHCl3); 1H NMR δ 1.43 (s, 9H), 2.90 (dd, 
1H, J = 8.2, 13.4), 3.07 (br s, 1H), 4.43 (br s, 1H), 4.43 (s, 1H), 4.74 (br s, 1H), 
5.18 (br s, 1H), 7.19-7.33 (m, 5H), 9.82 (s, 1H); 13C NMR δ 28.4, 38.5, 60.1, 
78.2, 79.5, 81.4, 127.0, 128.8, 129.6, 136.6, 152.7, 175.1; IR (film): 1704, 
1750, 2978 cm-1; HRMS (CI) calcd for C16H22NO5 308.1498 ([M+H]+), found 
308.1495. 
General procedure for dipeptides A28-Phe 
To crude ent-25A-Phe (76 mg, 0.23 mmol) in THF (25 mL) at 0 oC was added 
N-methylmorpholine (27 µL, 0.25 mmol) and isobutyl chloroformate (32 µL, 
0.25 mmol). After 5 min, L-leucine methyl ester (47 mg, 0.26 mmol) was 
added to the reaction mixture, and then the mixture was stirred at room 
temperature for 5 h. After the removal of the solvents, the residue was 




was extracted with EtOAc (20 mL  2), and the combined organic layers 
were dried over MgSO4, filtered and concentrated under reduced pressure. 
The organic residue was purified by silica gel chromatography 
(hexane:EtOAc = 8:1) to afford the desired ester of dipeptide A28-Phe.   
A28-Phe 
[3-(tert-Butoxycarbonyl-(4R,5S)-4-benzyloxazolidine-5-carboxylic acid]-L-
leucine methyl ester; 92% (94 mg); colorless oil; [α]15D  E = -10.7 (c = 0.96, 
CHCl3); 1H NMR (50 oC) δ 0.94 (d, 6H, J = 6.0), 1.40 (s, 9H), 1.52-1.63 (m, 
2H), 1.64-1.70 (m, 1H), 2.99 (dd, 1H, J = 5.8, 13.4), 3.08 (dd, 1H, J = 5.8, 
13.4), 3.74 (s, 3H), 4.34 (d, 1H, J = 3.2), 4.49-4.53 (m, 1H), 4.65-4.60 (m, 
1H), 6.78 (d, 1H, J = 8.0), 7.22-7.33 (m, 5H); 13C NMR δ 21.8, 22.8, 24.9, 
28.1, 38.8, 41.4, 50.2, 52.3, 60.0, 78.7, 80.5, 80.7, 126.7, 128.5, 129.8, 136.8, 
152.4, 169.9, 172.7; IR (film): 1156, 1698, 1742, 3335 cm-1; HRMS (CI) 
calcd for C23H35N2O6 435.2495 ([M+H]+), found 435.2491. 
A28-Phe’ for AHPBA-L-Val 
[3-(tert-Butoxycarbonyl-(4R,5S)-4-benzyloxazolidine-5-carboxylic acid]-L-
valine methyl ester; 70% (198 mg); colorless oil; [α]15D  E = -0.8 (c = 0.54, 
CHCl3); 1H NMR (50 oC) δ 0.89 (d, 3H, J = 6.0), 0.93 (d, 3H, J = 6.8), 1.38 (s, 
9H), 2.14-2.22 (m, 1H), 3.00 (dd, 1H, J = 6.2, 13.8), 3.08 (dd, 1H, J = 6.2, 
13.8), 3.76 (s, 3H), 4.35 (d, 1H, J = 3.2), 4.53-4.58 (br s, 1H), 5.28 (br s, 1H), 
6.9 (d, 1H, J = 8.0), 7.23-7.33 (m, 5H); 13C NMR δ 21.8, 22.8, 24.9, 28.1, 
38.8, 41.4, 50.2, 52.3, 60.0, 78.7, 80.5, 80.7, 126.7, 128.5, 129.8, 136.8, 152.4, 
169.9, 172.7; IR (film): 1162, 1696, 1741, 3354 cm-1; HRMS (CI) calcd for 






[3-tert-Butyl 5-methyl (4R,5S)-4-isobutyloxazoline-5-carboxylic acid]-L-
leucine methyl ester 74% (370 mg); colorless oil; 1H NMR δ 0.94 (dd, 3H, J = 
2.6, 6.2), 1.00 (t, 3H, J = 6.4), 1.47 (s, 9H), 1.54-1.63 (m, 3H), 1.66-1.77 (m, 
2H), 3.76 (s, 3H), 4.22 (d, 1H, J = 2.8), 4.38 (dt, 1H, J = 2.5, 7.3), 4.61-4.4.77 
(m, 1H), 4.77 (d, 1H, J = 4.8), 5.31 (br d, 1H, J = 3.2), 6.86 (d, 1H, J = 8.4); 
13C NMR δ 21.9, 22.4, 22.8, 24.9, 25.0, 28.3, 41.4, 42.7, 50.3, 52.3, 57.9, 78.2, 
80.9, 81.7, 152.9, 170.4, 172.9. 
A28-Val 
[3-tert-Butyl 5-methyl (4R,5S)-4-isopropyloxazoline-5-carboxylic acid]-L-
leucine methyl ester 76% (264 mg); colorless oil; 1H NMR δ 0.92 (dd, 3H, J = 
1.6, 6.4), 0.99 (t, 3H, J = 7.0), 1.45 (s, 9H), 1.54-1.61 (m, 2H), 1.63-1.69 (m, 
1H), 1.94-1.99 (m, 1H), 3.74 (s, 3H), 4.09-4.11 (m, 1H), 4.34 (d, 1H, J = 2.8), 
4.59-4.73 (m, 1H), 4.74 (d, 1H, J = 4.8), 5.32 (br s, 1H), 6.91 (d, 1H, J = 8.4); 
13C NMR δ 18.5, 18.8, 21.8, 22.8, 24.9, 28.2, 28.3, 31.4, 41.4, 50.3, 52.3, 64.8, 
79.2, 79.9, 80.9, 153.3, 170.9, 172.9. ; HRMS (FAB) calcd for C19H35N2O6 
387.2495 ([M+H]+), found 387.2496. 
A29 
(2S,3R)-3-Amino-2-hydroxy-5-methylhexanamido)-4-methylpentanoic acid; 
95% (235 mg); white powder; 1H NMR δ 0.85-0.93 (m, 12H), 1.36-1.50 (m, 
2H), 1.56-1.60 (m, 1H), 1.63-1.69 (m, 2H), 1.70-1.78 (m, 1H), 4.09 (d, 1H, 
4.8), 4.30 (dt, 1H, J = 4.8, 8.4), 6.44 (br s, 1H), 7.77 (br s, 2H), 8.12 (d, 1H, J 
= 7.6); 13C NMR δ 21.2, 21.4, 22.4, 22.4, 23.1, 24.1, 37.3, 50.0, 51.3, 69.7, 







quant. (223 mg); pale yellow powder; 1H NMR δ 0.91 (m, 12H), 1.38-1.47 (m, 
2H), 1.56-1.78 (m, 2H), 3.25 (d, 1H, J = 6.8), 4.09 (d, 1H, J = 6.8), 4.30 (qt, 
1H, J = 4.4), 6.46 (br s, 1H), 7.77 (s, 2H), 8.15 (s, 1H); 13C NMR δ 21.2, 21.4, 
22.4, 224, 23.1, 24.1, 37.4, 50.0, 51.3, 69.8, 170.8 173.1. 
Procedure for A31 
To a solution of ent-A23-Ser (297 mg, 0.791 mmol) in THF was added 
TBAF.H2O (213 mg, 0.815 mmol). The reaction mixture was stirred at for 1 h 
at room temperature and then partitioned between the saturated NH4Cl 
aqueous solution (10 mL × 2) and EtOAc (20 mL × 2). The comined 
organic layers were dried with MgSO4, filtered and concentrated under 
reduced pressure. 
 To the obtained crude of the desilylated product in aceton (3 mL) and an 
aqueous solution of 5% NaHCO3 (10 mL) a t 0 oC was added KBr (18 mg), 
TEMPO (185 mg) and then an aqueous solution of 12.5% NaOCl (3.164 mL). 
The resulting mixture was stirred for 3 h at room temperagure and then 
partitioned between H2O (20 mL × 2) and Et2O (20 mL × 2). The 
combined aqueous layers were acidified with an aqueous solution of 2 M HCl 
to pH 4~5 and then the resulting mixture was partitioned between brine (20 
mL × 2) and EtOAc (20 mL × 2). The combined organic layers were dried 
with MgSO4, filtered, and concentrated under reduced pressure. 
 To the obtained crude in diethyl ether (6 mL) and MeOH (2 mL), 2 M THF 
solution of TMSCHN2 was added, and then the reaction mixture was stirred at 




mixture was condensed under reduced pressure. The residue was purified with 
SiO2 column chromatography (4:1 Hex/EtOAc) to give A31 as colorless oil.  
A31 
(4S,5S)-3-tert-Butyl 4,5-dimethyl oxazolidine-3,4,5-tricarboxylate; 89% (204 
mg); colorless oil; 1H NMR δ 1.48 (s, 9H), 3.84 (s, 3H), 3.85 (s, 3H), 4.61-
4.75 (br d, 1H), 4.80 (d, 1H, J = 2.0), 5.02-5.10 (br d, 1H), 5.23 (s, 1H); 13C 
NMR δ 28.2, 52,8, 59.5, 60.2, 78.3, 79.8, 81.6, 151.7, 152.3, 169.4, 169.6.; 
HRMS (CI) calcd for C12H20NO7 290.1240 ([M+H]+), found 290.1237. 
Procedure for A32 
To a solution of A31 (93 mg, 0.321 mmol) in anhydrous CH2Cl2 (2 mL), TFA 
(1 mL) was added then stirred at room temperature overnight. After the 
removal of the organic solvents, the residue was partitioned between H2O (10 
mL × 2) and EtOAc (10 mL × 2). The combined aqueous layers were then 
condensed under reduced pressure.  
To the crude (88 mg, 0.321 mmol) in anhydrous MeOH (3 mL), Boc2O (0.103 
mL, 0.482 mmol) and Na2CO3 (51 mg, 0.482) were added, and then stirred 
under N2. After the reaction was completed, the reaction mixture was 
condensed under reduced pressure. Then the residue in EtOAc (10 mL) was 
acidified with an aqueous solution of 2 M HCl to pH 1 and then the resulting 
mixture was partitioned between brine (20 mL × 2) and EtOAc (20 mL × 
2). The combined organic layers were dried with MgSO4, filtered, and 
concentrated under reduced pressure. The residue was purified with SiO2 
column chromatography (4:1 Hex/EtOAc) to give A32 as colorless oil. 
A32 




(37 mg); colorless oil; 1H NMR δ 1.46 (s, 9H), 3.17 (d, 1H, J = 5.9), 3.84 (s, 
3H), 3.85 (s, 3H), 4.72 (dd, 1H, J = 1.8, 5.9), 4.81 (d, 1H, J = 9.0),5.29 (d, 1H, 
J = 9.0); 13C NMR δ 28.4, 52.9, 53.2, 56.1, 71.0, 80.4, 155.3, 166.9, 172.1; 
HRMS (CI) calcd for C12H20NO7 290.1240 ([M+H]+), found 290.1237. 
Procedure for A33 
To a solution of A32 (37 mg, 0.13 mmol) in DMF, BnBr (0.079 mL, 0.67), 
Ag2O (186 mg, 0.80 mmol), and TBAI (296 mg, 0.80 mmol) were added. 
Then the mixture was reacted in the dark overnight. The reaction mixture was 
filtered through Celite, washing through with ether (30 mL). The oraganic 
solution was washed with water (30 mL × 3). The organic layers were dried 
with MgSO4 and concentrated under reduced pressure. The residue was 




55% (27 mg); colorless oil; 1H NMR δ 1.45 (s, 9H), 3.65 (s, 3H), 3.77 (s, 3H), 
4.39 (d, 1H, J = 12.0), 4.51 (d, 1H, J = 2.1), 4.85 (dd, 1H, J = 2.1, 9.9), 4.84 
(d, 1H, J = 12.0), 5.39 (br d, 1H, J = 9.9); 13C NMR δ 28.2, 52.4, 52.6, 72.8, 
80.2, 128.1, 128.2, 128.3, 136.6, 155.5, 169.7, 169.7. 
Procedure for L-TBOA 
To the solution of A33 in THF, 2 M NaOH aqueous solution was added, and 
stirred at room temperature for 2 h. After the reaction was completed, the 
residue in EtOAc (10 mL) was acidified with an aqueous solution of 2 M HCl 
to pH 1 and then the resulting mixture was partitioned between brine (20 mL 




MgSO4, filtered, and concentrated under reduced pressure.  
To the solution of crude in anhydrous CH2Cl2 (2 mL), TFA (0.5 mL) was 
added and stirred at room temperature overnight. After the removal of the 
organic solvents, the residue was partitioned between H2O (10 mL × 2) and 
EtOAc (10 mL × 2). The combined aqueous layers were then condensed 
under reduced pressure to obtain L-TBOA as colorless oil. 
L-TBOA 
(2S,2S)-2-Amino-3-(benzyloxy)succinic acid; 93% (23 mg); colorless oil; 1H 
NMR (DCl) δ 4.22 (d, 1H, J = 2.4), 4.27 (d, 1H, J = 11.6), 4.36 (d, 1H, J = 
2.4), 4.52 (d, 1H, J = 11.6), 7.05-7.11 (m, 5H); 13C NMR δ 54.3, 73.4, 73.9, 
128.6, 128.7, 128.8, 135.7, 168.4, 171.5; HRMS (CI) calcd for C11H14NO5 
240.0872 ([M+H]+), found 240.0873. 
General procedure for dipeptides ent-A34 
To ent-A23-Val (183 mg, 0.67 mmol) in THF (6 mL) at 0 oC was added 2 N 
NaOH (6 mL). After the reaction misture was stirred at room temperature for 
1 h, it was acidified with 2 N HCl to pH 1 at 0 oC. The reaction mixture was 
then partitioned between EtOAc (20 mL) and brine (5 mL). The aqueous 
phase was extracted with EtOAc (20 mL  2), and the combined organic 
layers were dried over MgSO4, filtered and concentrated under reduced 
pressure. 
To the obtained crude in THF at 0 oC, HOBt (109 mg, 0.804 mmol) and L-
Val-OtBu (154 mg, 0.737 mmol) were added. EDC (154 mg, 0.804 mmol), 
and N, N-diisopropylethylamine (0.282 mL, 2.01 mmol) were added to the 
reaction mixture. The mixture was stirred at room temperature overnight. 




saturated aqueous solution of NH4Cl (20 mL) and EtOAc (20 mL). The 
aqueous phase was extracted with EtOAc (20 mL  2), and the combined 
organic layers were dried over MgSO4, filtered and concentrated under 
reduced pressure. The organic residue was purified by silica gel 
chromatography (hexane:EtOAc = 8:1) to afford the desired ester of dipeptide 
ent-A34.   
ent-A34 
[3-tert-Butyl 5-methyl (4R,5S)-4-isopropyloxazoline-5-carboxylic acid]-L-
valine tert-butyl ester; 54% (149 mg); colorless oil; 1H NMR δ 0.87 (d, 3H, J 
= 6.8), 0.92 (d, 3H, J = 7.2), 1.01 (d, 3H, J = 6.4), 1.04 (d, 3H, J = 6.8), 1.46 
(s, 9H), 1.97 (br s, 1H), 2.15-2.23 (m, 1H), 4.35 (d, 1H, J = 2), 4.46 (dd, 1H, J 
= 4.6, 8.7), 4.78 (d, 1H, J = 4.6), 5.42 (br s, 1H), 7.04 (d, 1H, 8.7); 13C NMR δ 
17.4, 17.6, 18.7, 18.8, 18.9, 18.9, 19.0, 19.2, 28.1, 31.5, 56.8, 65.3, 79.3, 80.7, 
82.2, 153.4, 170.6, 171.0; HRMS (FAB) calcd for C21H39N2O6 415.2808 
([M+H]+), found 415.2792. 
A35 
(2S,3R)-3-Amino-2-hydroxy-4-methylpentanamido-3-methylbutanoic acid; 
quant. (133 mg); colorless oil; 1H NMR (DMSO-d6) δ 0.91 (d, 1H, J = 7.2), 
0.92 (d, 1H, J = 6.8), 0.95 (d, 1H, J = 8.8), 0.97 (d, 1H, J = 9.2), 1.88-1.95 (m, 
1H), 2.07-2.15 (m, 1H), 3.03 (d, 1H, J = 4.4), 4.15 (dd, 1H, J = 5.6, 8.0), 4.26 
(d, 1H, J = 4.4), 7.77 (s, 2H), 8.13 (d, 1H, J = 8.0); 13C NMR δ 17.8, 18.1 , 



















Figure B1. The structure of acetaminophen. 
 
Acetaminophen (Fig. B1), also known as paracetamol or N-acetyl-p-
aminophenol, 1 is a popular analgesic for headache or other minor pains, and it 
is also a major ingredient in cold and flu treatment as an antipyretic. These 
analgesic and antipyretic properties of acetaminophen are similar to that of 
non-steroidal anti-inflammatory drugs (NSAIDs), but it does not possess any 
anti-inflammatory activity, which is contrary to NSAIDs. When 
acetaminophen is applied in recommended doses, it does not induce 
gastrointestinal bleeding that is a typical side effect from NSAIDs although it 
suppresses prostaglandin production likewise NSAIDs. Due to lack of an anti-
inflammatory effect, acetaminophen has not been regarded as a member of the 
NSAIDs family. 
Acetaminophen was introduced into the pharmacological market in 1955 by 




under its trade name Tylenol Children’s Elixir. The discovery of 
acetaminophen was derived from acetanilide (Fig. B2), whose antipyretic 
effect was found by chance during the eradiation of worms in 1880s.2 For 
many years after its discovery in 1886, acetanilide was used as an alternative 
to aspirin (acetyl salicylate) that showed gastrointestinal, ulcer or stomach 
bleeding and ringing in the ears, especially with higher doses. Acetanilide, 
however, could not be used as antipyretic medicine due to its high toxicity 
since 1948, when Julius Axelrod and Bernard Brodie discovered that 
acetanilide caused methemoglovinemia and ultimately caused damage to the 








acetanilide phenacetin  
Figure B2. Structure of acetanilide and phenacetin. 
 
In order to alleviate toxicity of acetanilide, phenacetin and acetaminophen 
had been synthesized as its derivatives.3 Among the derivatives, phenacetin 
(Fig. B2) was introduced into medical practice in 1887 earlier than 
acetaminophen due to the faulty conclusion on the first clinical trials of 
acetaminophen. In the first trials with acetaminophen, its toxicity was 
estimated as much as that of acetanilide, but Bernard Brodies and Julius 
Axelrod demonstrated that acetaminophen was the main active metabolite of 
acetanilide and phenacetin responsible for their analgesic and antipyretic 
action in 1948.4 Since then, acetaminophen had become a popular analgesic 




because of its side effect, which caused the analgesic nephropathy with a 
prolonged usage.5  
Although acetaminophen had been widely used in medical practice for more 
than half the century, its mechanism of action has not been elucidated until 
now.6 The verified effects are known as being related to both the peripheral 
(cyclooxygenase (COX) inhibition), and central (COX, serotonergic 
descending neuronal pathway, L-arginine/NO pathway, cannabinoid system) 
antinociception process and “redox” mechanism.4 As like shown in Scheme 
B1, the COX enzymes are responsible for the conversion of arachidonic acid 
to prostaglandin H2, which is an unstable molecule that is converted to 
numerous other pro-imflammatory compounds. In the production of 
prostaglandin H2, the COX enzymes are participated as thier oxidized forms. 
Therefore, the anti-inflammatory agents usually block the oxidation of the 
COX enzyme so that the unstable molecule for pro-inflammatory compounds 
could not be synthesized by COX enzyme. Acetaminophen also reduces the 














Scheme B1. Prostaglandin H2 synthesis with COX. 
 
Based on its relatively stable nature of acetaminophen, more than 600 




distributed worldwide. According to the report by FDA in 2009, over 370 
million bottles and packets (24.5 billion tablets) of acetaminophen products 
was sold in 2008, and it recorded $2.6 billion in sale (Fig. B3). Furthermore, 




Figure B3. Total sales of acetaminophen containing products in the US.7 
 
Acetaminophen has also permeated as an easily accecable analgesic in Korea. 
Tyrenol, one of the typical over-the-counter analgesics including 
acetaminophen as an a main ingredient, was sold over 25 billion won in 2011 
and the total sales of the other popular analgesics containing acetaminophen, 
such as Geworin, Panpyrin Q and Ultracet, was recorded in 77 billion won in 
2011 according to the report from Korea Health Industry Development 









2. Conventional process for Acetaminophen 
 The conventional process for acetaminophen started with chlorobenzene or 
phenol (Scheme B2). Regardless of the starting material, the first step is 
nitration, which produces the mixture of o-, m-, p- regioisomers, and the 
desired p-regioisomer, p-chlorobenzene or p-nitrophenol, is separated befor 




































Scheme B2. Convenstional process for acetaminophen. 
 
 The key intermediate, p-aminophenol, is produced by the reduction of p-




the conventional process for acetaminophen.10 Because the nitration of 
chlorobenzene or phenol accompanies with the undesired regioisomers that 
require an additional separation process for the desired p-nitro compounds, 
the conventional process has been developed for more efficient production of 
p-aminophenol with reducing the undesired regioisomers. 
Two alternative routes have been reported to improve the regioselectivity on 
the sytnehsis of p-aminophenol. One of the alternative processes is Hoechst-
Celanes process which utilizes Fries rearrangement for the preparation of 
acetophenone from phenol and the following Beckmann rearrangement 
converting the acetoxy moiety to acetamido functional group (Scheme B2 (a)). 
11 
Another alternative route starts with nitrobenzene, which is readily prepared 
from the nitration of benzene. Under the catalytic hydrogenation reaction 
conditions, nitro group is reduced to N-phenylhydroxylamine, and then the 
hydroxylamine is successfully converted to p-aminophenol under acidic 
reaction conditions via Bamberger rearramgenemt.12 The acetylation of the 
















































However, these alternative processes also reveal some drawbacks. In 
Hoechest-Celanese process, the used acid catalyst (H2F2) is too virulent to be 
used in large scale process although the condensation with acetic anhydride 
and phenol under the acid catalyst has been successful. In Bamberger 
rearrangement with nitrobenzene the production of aniline is a predictable 
defect of the process even though nitrobenzene is cheaper than the nitrophenol. 
Like this, the alternative processes have not completely reformed the 
selectivity issue in the conventional process due to their own problems. 
Besides the regioselecvity, furthermore, the conventional process involves 
other drawbacks.     
The process environment of acetaminophen production on the conventional 
or the alternative methods could be considered as harmful or sometimes 
hazardous because mineral acids are used in the key reactions, even 
sometimes used as reaction solvents, which are applied as aqueous solution of 
them. The usage of mineral acids causes the erosion of the reactor, and an 
additional process to treat the waste acids is necessary at the end of the 
reaction.  
Another drawback is related to the qulity control. The synthesized 
acetaminophen has to meet the National Formlary specification in order to 
qulify for use in the pharmaceutical field and indeed in many non-
pharmaceutical applications. However, acetaminophen from the process 
containing p-aminophenol as a key intermediate often contains numerous 
colored compounds or colored impurities, which are exceedingly difficult to 











blue color in acidic sol'n
yellow color in basic sol'n
Indophenol
red color in acidic sol'n




Figure B5. Possible colored imputies on the synthesis of p-aminophenol. 
These colored compounds have not been precisely verified, but it is assumed 
that they are comprised of quinones, quinonimies and meri-quinonimines that 
are produced by the oxidation of p-aminophenol derivatives (Figure B4).13 
These oxidations undoubtedly occur as side reactions during the preparation 
of work-up of p-aminophenol, which is usually formulated with low 
concentration of antioxidants to avoid undesired oxidation. Its oxidative 
property also requires a careful treatment of the industrial waste water 
because it could be reacted with the dissolved oxygen, which is intimately 
related to the aquatic life.    
Finally, the number of the steps in the conventional process with 
chlorobenzene is 4 by excluding the additional regioisomer separation step 
and the subsidiary waste acids (or water) treatment process. Although 
chlorobenzene can be converted to the desired product via the four reaction 
steps- nitration, hydroxylatiom, reduction and acetylation, each step requires a 
workup and purification processes and careful treatment process for waste 
acids. Due to the repetitive cumbersome workup and purification processes, 
in-situ acetylation has been applied during the reduction of nitro group.14 The 




processes but also reduce the possibility on the formation of the previously 
mentioned colored impurities. Also, simple and efficient purification methods 
have been reported.15 However, the overall process development has not been 
tried for acetaminophen yet whereas new concepts have been applied to 
develop a process for ibuprofen, another safe analgesic.16 For example, a 
continuous-flow processing has been developed for the efficient and practical 
production of ibuprofen (Fig. B6). In the new process, the production rate was 
measured as 8.09 g/ hr. 
 
Figure B6. Continuous flow process for another analgesic, ibuprofen. 
Therefore, a new efficient and eco-friendly process development has been 
planned to solve the chronic problems in acetaminophen production. While 
the previously developed processes utilize p-aminophenol as a key 
intermediate, the new process does not contain p-aminophenol at all. The 
nitration with the mixed strong acids or the reduction of nitro group in acidic 
aqueous solution is no more required, and the long process steps are going to 




regioselectivity issue is not considered with the new process anymore. The 
new process, which is seemed like an ideal process for acetaminophen, is 
planned based on the following previous studies on the regioselective 
synthesis of p-dihalobenzene and the metal catalyzed cross coupling reaction 





3. Regioselective halogenation for p-dihalobenzene 
Halogenation, which occurs via the electrophilic substitution reaction, is 
essential in organic synthesis because the halogenated organic compounds are 
generally applied as useful synthetic intermediates for preparation of 
pharmaceuticals, pesticides, agricultural chemicals, and bioactive compounds. 
One of the well-known applications of the halogenated compounds is various 
cross coupling reactions which use them as useful substrates.17  
The halogenation of unsaturated hydrocarbons is performed with halogen-
based oxidants, including elemental halogens (X2, X=halides), organic or 
inorganic hyprohalites (XO-), hypervaltent iodine reagents, dihalo-5,5-
dimethylhydantoins and N-halosuccinimide (Fig. B7).  In other words, the 
halogenation occurs from oxidative halogenation, in which a halide ion is 
oxidized to a halogenating reagent, a positive halogen (Cl+, Br+, I+). There is 
an exception with floride in the oxidative halogenation becuase it is too 

































Figure B7. Common halogen-based oxidants. 
 




methods for halgenate unsaturated hydrocarbons or aromatic compounds have 
been developed. Especially, these days, green oxidative halogenation has been 
explored based on green chemistry perspectives, where halide salts have been 
applied with H2O2 to form the corresponding positive halogens. There have 
been reported some regioselective halogenation to form p-dihalobenzenes. 
The following examples are related to the regioselective halogenations for p-
regioisomers of phenol, aniline or monohalobenzenes, which are concerned as 
potential starting materials in the development of a new process for 
acetaminophen. 
 







































Chem. Commun., 2004, 2614
I
(b) Electrophilic reagent


















































para : ortho = 90:10








KI, Na2O4W, H2O2 (or NaBO3l)





83% with NaBO3 (para only)
96% with H2O2 (para only)
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The regioselectivity on iodination of phenol or aniline is varied from ortho- 
to para- depending on the reaction conditions and other substituents on 
phenol or aniline. As like depicted in the figure B8, the ratio of p-isomer to o-
isomer is increased when phenol is treated with CAN instead of H2O2 whereas 
the ratio of p-iodoaniline is decreased by applying CAN (Figure B8 (a)). 
Triiodoisocyanuric acid is successfully applied on the regioselective 
iodination of phenol and aniline, which are converted to p-isomers (Figure B8 
(b)). However, halogenation with halogen or the activated reagent, such as 
NBS or triiodoisocyanuric acid, is considered as hazardous or non-
environmental friendly.  
Therefore, there have been various studies on halogenation with halide salt 
from green chemistry perspective. Some selective examples of halogenation 
with halide salt are presented in figure B8 (c). N-Acetylaniline is also 
successfully converted to N-acetyl-p-haloaniline and the yield of the desired 
product is usually reported in more than 80%. Moreover, both inorganic and 
organic halide salts are successfully applied with various oxidants. Among the 
selected examples, the regioselective iodination with 3,5-dihydroperoxy-3,5-
dimethyl-1,2-dioxolane takes more attention beause benzene is converted to 
p-diiodobenzene in 72% yield because the previously mentioned process 
development of acetaminophen has been planned with p-dihalobenzene. 
Based on the purpose of the study, regoiselective halogenation for p-




(c) Halide salt with oxidant
Ar-H














































































(a) Bromine with catalyst
Ar-H























Similar to the previously mentioned examples with phenol and aniline, the 
halogen or the activated halogen reagents generally produce the mixture of p- 
and o- isomers, but the ratio of p-isomer to o-isomer is better than that of 
phenol and aniline. With halide salts, p-dihalobenzene has been prepared 
dominantly in the presence of oxidants. N-Acetyl-p-iodoaniline is synthesized 
in 94% yield with sodium iodide and cerium (IV) trihydroxide hydroperoxide 
(Fig. B9 (c)). Moreover, the practical process for the production of p-
diiodobenzene has been developed (Fig. B10).17 In the process, benzene is 
regioselectively converted to p-diiodobenzene in the presence of Fe2O3/ 




Figure B10. Practical process for p-diidobenzene. 
 
Based on the regioselective halogenations with halobenzene, phenol or 
aniline, a new process development of acetaminophen takes possibility of 
realization. The halogenated compounds, as like previously mentioned, are 
usually applied on various cross-coupling reactions to from new C-C, C-N or 




to be utilized with p-dihalobenzenes in the new process development of 
acetaminophen. Among the well-developed cross-coupling reaction, 
Goldberg18 reaction for C-N bond and Ullmann-type condensation19 for C-O 
bond are selected. Before starting the development of a new process, I took a 






 4. Goldberg and Ullmann type condensation reactions 
Functionalized aromatic and heteroaromatic amines are key building blocks 
for the synthesis of pharmaceuticals, polymers or materials.20 In recognition 
of their widespread importance, many synthetic methods have emerged over 
the years for the formation of C-O and C-N bonds, trying to overcome the 










(a) Goldberg reaction (1906)
OH Br
Cu, KOH
210 ~ 230 oC O
(b) Ullann condensation reaction (1906)
  
Scheme B4. Goldberg and Ullmann condensation reactions. 
 
 An advanced method from Goldberg reaction was reported by Buckwald 
who applied diamine ligands for more efficient amination with alkylamines 
because the use of aliphatic amines had been a long-standing problem.22 
Before then, only chelating substrates, such as a- and β-amino acids and β-
amino alcohols were possible to undergo the amination with aryl halides in 
the presence of copper catalysts. Buckwald’s method was operationally simple 




efficiently used for the coupling of a variety of functionalized arylating agents 
with several amines. Besides ethylene glycol, various ligands had been 
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Figure B11. Various ligands for copper catalyzed amination. 
 
With the development of new ligands that enable reactions performed under 
milder conditions with improved yields, the copper catalyzed arylation of 
aliphatic amines had clearly become a powerful tool for the preparation of 
functionalized alkylarylamines. Simiar to the amination, the arylation of 
amides had also received considerable attention over the past decade due to its 
high synthetic utility. The introduction of chelating lignads resulted in major 




the original procedure of Goldberg reaction.19 The following figure showed 
general substrates and diamine lignads, which had been successfully 





X = I, Br, Cl









R1 = H, Me, Ph, Bn, cyc-Hex, etc.


































 Figure B12. General substrates and ligands for arylamide synthesis. 
 
Buckwald and co-workers extensively studied the reaction conditions and 
developed the inexpensive catalytic system, copper catalyzed system, based 
on the use of 1,2-diamine ligands (Fig. B12 (c)). Under the reaction 
conditions, aryl chloride and acyclic secondary amides were effectively 
coupled, and a variety of functional groups were tolerated in the reaction, 




Furthermore, the reaction for aryl amide had been extended to the use of other 
coupling partner, such as carbamates. 
In the C-O bond formation, which had also been advanced as like the C-N 
bond formation, one of the major drawbacks of the classical Ullmann biaryl 
ether synthesis18 was the use of a strong base, such as tert-butoxide. Buckwald 
introduced cesium carbonate, instead of a strong base, and the preparation of 
diaryl ether had been performed via the improved procedure. Based on the 
improved procedure, ary-alkyl ether formation also had been possible with the 
use of milder bases, such as cesium carbonates. The first example on the 
reactions between a wide variety of alcohols and aryl halides had been 
reported by pioneering work by Hartwig and Buchwald in the presence of 
palladium catalysts. However, the use of palladium as catalysts limited ligand 
availability due to the β-hydride elimination of alcohols possessing β-
hydrogens. Copper based catalysts provided more reliable activities because 
the intermediates derived from these catalysts did not readily undergo β-
hydride eliminations. The first successful application of copper-mediated 
arylation of aliphatic alcohols was reported in 2002 by Buckwald, using 
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 Figure B13. General substrates and ligands for ether formation. 
 
Aryl-alkyl ether could be obtained in excellent yields starting from primary, 
secondary, benzyl, allyl and propagyl alcohols. Like the previously mentioned, 
Cs2CO3 was applied as common base, and the reacting alcohol was usually 
applied as the solvent. These reaction conditions had also utilized for 
hydroxylation of aryl halide with K3PO4 in the presence of water,24 contrary to 
that the original hydroxylation of aryl halide required hydroxide.  
Based on the previous researches on the regioselective dihalobenzene 
preparation and two copper-catalyzed coupling reactions, a new process had 







Figure B14. A new approach for efficient acetaminophen synthesis. 
 
The previously mentioned drawbacks on the conventional process of 
acetaminophen would be solved with the greener and more efficient process 
via well-developed copper-catalyzed reactions. The detailed results of the new 





Results and Discussions 
 
1. The development of a new efficient process for acetaminophen 
In the beginning of the synthesis of acetaminophen, two possible routes had 
been considered with p-diiodobenzene (Scheme B5). In route A, C-N bond 
formation was performed prior to the formation of C-O bond while the metal 






















Scheme B5. Possible routes with p-diiodobenzene. 
 
First, route A was closely considered as a potential synthetic route. There had 
been several examples on the diamination or diacetamidation25b with 
dihalobenzene, and hydroxylation reaction conditions generally required 
hydroxide as base, which could hydrolize N-acetyl moiety to amine. Based on 
these reported results, route A seemed like showing low possibility at first 
glance. However, there had much more examples on the amidation with p-
dihalobenzenes23 where amidated mono-halo benzenes were produced in 
higher yields. In addition, other milder reaction conditions for hydroxylation 
with aryl halide had been reported. One of them used water as the reaction 




or nBu4NBr.25b Under the milder reaction conditions, the desired 
hydroxylation with various substituted aryl halide was performed. 
When the hydroxylation was performed first, however, there was a 
possibility of the formation of benzene,25d hydroquinone,26a or phenol,26b 
instead of p-iodophenol26 depending on the solvent, bases and oxygen 
source.27 Although the amidation of halophenol was expected to show similar 
results with anisole compounds, whose yield was mostly over 80%, the route 
B could not be an efficient process if the undesired reactions were occurred in 
the hydroxylation conditions.  
With the extensive investigation on hydroxylation and acetamidation with p-
dihalobenzene, each first step in the route A and B had been tried with 
diamine ligand, N,N’-dimethylethylene diamine (DMEDA) in the presence of 
CuI and CsF as catalyst and base, respectively. Although the desired 
acetamidation had been performed with acetamide and p-diiodobenzene, the 
hydroxylated product, p-iodophenol, had not been observed after the reaction 
in water. Therefore, the route A, where acetamidation of p-dihalobenzene was 






2. Acetaminophen synthesis from p-diiodobenzene 
An efficient process development for acetaminophen had been started to find 
an optimized conditions of the route A in Scheme B5. Among the well-
developed synthetic methods for N-aryl amide and phenol, the combination of 
the inexpensive copper catalyst and diamine ligand was chosen for a new 
process.21, 22  
In order to optimize the reaction conditions with acetamide, various Cu 
catalysts had been applied. Besides to copper catalysts, commonly used 
palladium catalysts also had been applied (Table B1). Other reaction 










cat.(2 mol%), DMEDA (20 mol%)
acetamide (2.2 eq.), K3PO4 (2.2 eq.) 
DMF (0.2 M sol'n), 110 oC  
Entry Catalyst Yield Sm recovered 
1 CuI 51% 16% 
2 CuBr 5% 80% 
3 CuCl 10% 80% 
4 CuCN 15% 40% 
5 CuTC 10% - 
6 CuSO4 6% 12% 
7 CuCl2 13% 63% 
8 Cu(OTf)2 28% 41% 
9 (CuOTf)2Benzene 3% 80% 
10 Pd(OAc)2 a 8% 90% 
11 Pd2dba3 a 51% 33% 
a Cs2CO3 and Xantphos are used as base and ligand. 
 
According to the results of the catalysts’ screening, CuI (Entry 1) and 
Pd2dba3 (Entry 11) shown the best results with accompanying 16%, or 33% of 
starting material recovery, respectively. Interestingly, copper bromide (Entry 
2) and copper chloride (Entry 3) were almost intact to the amidation between 
acetamide and p-diiodobenzene (PDIB). Moreover, cupric(II) triflate (Entry 8) 
presented better yield of the desired product, N-acetyl-p-iodoaniline, than that 
with cuprous(I) triflate (Entry 9), which is complexed with benzene. With 
CuTC (Entry 5), only 10% of the desired product was obtained without the 
starting material recovery.     




Glycine, proline and N,N-dimethyl glycine had been tested with CuI in 0.5 M 
DMF solution of PDIB (Table B2). 
 





CuI (2 mol%), Ligand (20 mol%)
acetamide (2.2 eq.), K3PO4 (2.2 eq.) 
DMF (0.2 M sol'n), 110 oC  
Entry Ligand Resultsa 




3  No rxn 
4  product:sm = 94 : 5 
a Determined by GC; b. Cu(OTf)2 was used instead of CuI; c. CsF is used as base in THF. 
 
Although glycine and N,N-dimethyl glycine, which were reported as 
efficient lignads with copper catalysts, did not produce the desired product 
with acetamide,  L-proline efficientely helped the copper catalyst on the 
acetamidation reaction. Another ligand screening study had been performed 



















CuI (2 mol%), Ligand (20 mol%)
acetamide (2.2 eq.), K3PO4 (2.2 eq.) 
DMF (0.2 M sol'n), 110 oC  
Entry Ligand Resultsa 
1 
 
Product : sm = 43 : 39 
2 
 






Product : sm = 64:32 
5 
 
Product : sm = 79: 6 
6  Product : sm = 51:16 






























The applied diamine ligands were ethylenediamine (L1), N,N’-
dimethylethylene diamine (DMEDA, L2), trans-1,2-diaminocyclohexane 
(L3), trans-N,N’-dimethylcyclohexane-1,2-diamine (L4), and 1,10-
phenanthroline (L5), which are shown in figure B8, and N,N,N’,N’-
tetramethylethylene diamine (not shown in Fig B8). According to the results 
from the entry 1 to 3 in the table B3, the number of the substituted methyl on 
amine is seemed like a key factor on the ligand ability. Among them, the 
dimethyl amine showed the best conversion while the tetramethyl amine did 
not participate the cross coupling reaction with the copper catalyst at all. The 
unsubstituted diamine ligand (Entry 1) produced the desired amidated product 
with low conversion. The similar results had been observed with 
cyclohexandiamine (Entry 4) and dimethylcyclohexanediamine (Entry 5). The 
L4 had coverted the most of the starting materials to the desired products 
while almost only half of the starting material had been participate the 
amidation with the L3. With 1,10-phenanatroline, 51% of conversion had 
been observed. 
According to the obtained results with various diamine ligands, N,N’-
dimethyl substituted diamine ligands (Entry 2 and 5) had been selected as the 
most efficient ligand with copper iodide. Among the two dimethyl substituted 
diamine ligands, DMEDA (L2) was chosen for the rest of the reaction 
screening because it was cheaper than trans-N,N’-
dimethylcyclohexanediamine (L4). Therefore, the most effective combination 
of catalyst and ligand in acetamidation is the combination of CuI and 
DMEDA (L2). 




progressed in 1 M DMF solution of p-diiodobenzene. The results were shown 
in Table B4 and B5. First, the commonly applied bases, such as K3PO4 and 
Cs2CO3, had been screened and the corresponding results were depicted in the 
table B4. 
 





CuI (2 mol%), DMEDA (20 mol%)
acetamide (2.2 eq.), bases (2.2 eq.) 
DMF (1 M sol'n), 90 oC  
Entry Base Yielda Sm recovered 
1 K3PO4 (powder) 33% 32% 
2 K3PO4 (granular) 45% 33% 
3 K2CO3 23% 4% 
4 Cs2CO3 37% 48% 
a Isolated yield. 
 
 The phosphate bases (Entry 1-2) showed better results than the carbonated 
bases (Entry 3-4), and the granular type of potassium phosphate (Entry 2) 
gave better result with 45% of the desired acetamidated product.   
Although the progressed results showed the optimized results with CuI, 
DMEDA and gracular K3PO4 as catalyst, ligand and base, the yield of the 
obtained product was still not satisfied. Therefore, the reaction solvent had 
changed to tetrahydrofuran (THF), having lower boiling temperature and 
easier to removed than DMF, and other types of base had been applied. The 










CuI (2 mol%), DMEDA (20 mol%)
acetamide (2.2 eq.), bases (2.2 eq.) 
THF (0.5 M sol'n), reflux  
Entry Base Resultsa 
1 KF product : sm = 5 : 95 
2 NaF product : sm = 3: 93 
3 CsF product : sm = 97 : 2 
4 nBu4NF product : sm = 63 : 13 
a Determined by GC. 
  
Potassium fluoride (Entry 1, Table B5) and sodium fluroride (Entry 2) 
showed the disappointed results, the majority of the starting material had been 
remained after the acetamidation in 0.5 M THF solution. Surprisingly, cesium 
fluoride (Entry 3) gave the highest conversion of p-diiodobenzne although 
teterabutylammonium fluoride (TBAF) affored the moderated conversion 
(Entry 4).  
In order to find suitable solvent with the obtained results, commonly used 
several organic solvents had been applied to the optimized reaction conditions, 
shown in table B6. Ethylacetate (EA), THF and acetonitrile (MeCN) had 
showed high conversion ratio (Entry 2-4) under the reflux conditions, but low 
conversion (28%, Entry 1) was observed in DMF at 100 oC. The disappointed 
result in DMF might be cuased by insufficient reaction temperature, but the 
reaction temperature screening had not been performed because DMF has 
high boiling point and it is hard to be removed after the reaction completed. 
Moreover, low reaction temperature can be an advantage on the new process 




difficulties during workup process. From these reasons, THF showing highest 
conversion was chosen as a proper solvent at acetamination step. 
 





CuI (2 mol%), DMEDA (20 mol%)
acetamide (2.2 eq.), CsF (2.2 eq.) 
solvent (0.5 M sol'n), reflux  
Entry Solvent Resultsa 
1 DMFb product : sm = 23 : 77 
2 Ethylacetate (EA) product : sm = 78 : 22 
3 THF product : sm = 97 : 2 
4 Acetonitrile (MeCN) product : sm = 87 : 7 
a Determined by GC.; b Reacted at 100 oC 
 
 In summary, the optimized reaction conditions with p-diiodobenzene 
include the combination of CuI and DMEDA (L2, Figure B8) and CsF as 
catalyst, ligand, and base in 0.5 M THF solution of p-diiodobenzen (Scheme 
B7). After the completion of the reaction, the pure product was obtained via 









THF (0.5 M)  
Scheme B6. Acetamidation with PDIB under the optimized conditions. 
 
The next step for acetaminophen had been explored after the establishment 




starting material, N-acetyl-p-iodoaniline had been synthesized by acetylation 











Scheme B7. The preparation of N-acetyl-p-iodoaniline. 
 
 Like the previously mentioned in the introduction, hydroxylation with 
copper catalyst usullay required metal hydroxide as bases. One of the 
previously developed reaction conditions using hydroxide as base had been 
applied with N-acetyl-p-iodoaniline although the hydrolysis of N-acetyl group 
had been expected. In the presence of CuI and dibenzoylmethane as catalyst 
and ligand, 57% of starting material was recovered, and the expected side 
product, 4-iodoaniline, was obtained with KOH. When CsOH. H2O was added 
to the reaction conditions, 16% of starting material was recovered with 4-
iodoaniline. However, acetanilide was observed with granule of K3PO4 in the 
presence of DMEDA as ligand instead of dibenzoylmethane.       
 Based on the results with K3PO4, another reaction conditions had been 
applied in water under the microwave irradiation reaction conditions without 
organic solvents. In order to find suitable hydroxylation reaction conditons 
with N-acetyl-p-iodoaniline, potent catalysts had been applied with DMEDA 












DMEDA (50 mol%), K3PO4 (2.2 eq.) 
H2O, 180 
oC, MW  
Entry Catalyst Resultsa 
1 CuIb Undesired reaction 
2 CuI product : sm = 69 : 31c 
3 Cu(OTf)2 product : sm = 66 : 19 
4 (Cu(OAc)2 product : sm = 66 : 17 
5 FeCl3 (0.2 eq.)b 
sm recovery with 
acetanilide 
6 FeCl3 (0.2 eq.), Cu2O (0.1 eq.)b product : sm = 36 : 19 
a Determined by GC; b Reacted at 160 oC; c Isolation yield is 49% 
 
 When CuI was added to the reaction mixture, the desired product could be 
obtained at 180 oC (Entry 2), but at 160 oC (Entry 1) undesired reaction had 
been progressed. With other copper catalysts (Entry 3-4), such as Cu(OTf)2 
and Cu(OAc)2, similar conversion had been observed comparing to the result 
with CuI. When FeCl3 had been applied as a catalyst (Entry 5), starting 
material was recovered with the side product, acetanilide. Contrary to this, the 
addition of Cu2O as an additional catalyst with FeCl3 afforded the desired 
product (Entry 6).  From the screening results of catalysts, acetaminophen 
was synthesized in 49% isolated yield with CuI as catalyst under the 
microwave irradiation. In order to improve the yield of the desired product, 




 The screening reults of bases had been summarized in table B8. K3PO4, 
commonly used in the hydroxylation in water according to the previously 
reported conditions, was reexammed with CuI and DMEDA under microwave 
irradiation (Entry 1). However, the common base, K3PO4, in cross coupling 
reaction for C-N or C-O bond formation did produce the mixture of 
acetanilide and aniline instead of acetaminophen. By changing the amount of 
CsF and concentration of the reaction mixture, the yield of acetaminophen had 
been increased upto 66%. Excess of CsF seemed like improving the yield of 
the desired product (Entry 2, 4-6, Table 8). At the low concentration, the 
stoichiometric amount of CsF presented acetaminophen in 66% of isolated 
yield.  
 







DMEDA (50 mol%), bases (2.2 eq.) 
H2O (0.5 M), 180 
oC, MW  
Entry Base Acetaminophena Acetaniline 
1 K3PO4 (2 eq.) 
the mxture of acetanilide and 
anilineb 
2 CsF (1 eq.) 48% 21% 
3 CsF (1 eq.) 66% 13% 
4 CsF (2 eq.) 43% 19% 
5 CsF (3 eq.) 41% 12% 
6 CsF (5 eq.) 55% 13% 





Based on the improvment at lower concentration of the reaction mixture, the 
addition of organic co-solvent had been under consideration. It seemed like 
one of the reason on the low yields at hydroxylation that insufficient solubility 
of N-acetyl-p-iodoaniline in water. However, the best result was observed in 
water system without any of organic solvents although the addition of organic 
solvent imporved the solubility of N-acetyl-p-iodoaniline (Table B9). 
 







DMEDA (50 mol%), CsF (1 eq.) 
H2O, 180 
oC, MW  
Entry Co-solvent system Resultsa 
1 DMSO : H2O = 1 : 1 product : acetanilide = 14 : 86 
2 DMSO : H2O = 1 : 3 product : acetanilide = 50 : 50 
3 THF : H2O = 1 : 3 product : starting mat. = 43 :47b 
4 H2O only product : acetanilide = 69 : 31 
a Determined by GC; b Isolation yield and reacted at 160 oC. 
 
Although the co-solvent system of DMSO and water did not improved the 
previous results (Entry 1-2, Table B9), the other co-solvent system with THF 
and water did not produce the side product but recover the starting material in 
47% isolated yield, which remained the possibility of the improved results on 
hydroxylation.  
In summary, the hydroxylation of N-acetyl-p-iodoaniline in water had been 
operated at 180 oC by heating with microwave irradiation in the presence of 




however, the control of the reaction temperature by microwave irradiation had 
not been generally used. Therefore, the optimized reaction was exposed to the 
normal heating reaction conditions (Table B10). With the DMSO as co-
solvent, majority of the starting material had been recovered at 100 oC (Entry 
1). The reaction vessel was changed to sealed pressure tube from opened 
reaction vessel, and the reaction temperature had been increased to 110 oC or 
130 oC (Entry 2-3). At the elevated reaction temperature, the desired product 
was obtained in 47% isolated yield. 
 






DMEDA (50 mol%), CsF (1 eq.) 
H2O  
Entry Concentration Rxn vessel Bath temp Resultsa 
1 0.5 M Opened tube 100 oC 82% of sm 
2 0.25 M Pressure tube 110 oC 32% of sm 
3 0.125 M Pressure tube 130 oC 47%  
a Isolated yields. 
 
 
In conclusion, p-diiodobenzene (PDIB) was successfully converted to N-
acetyl-p-iodoanilne via CuI-catalyzed reaction with DMEDA as ligand with 
97% of convertion and 62% of isolated yield. The following hydroxylation of 
N-acetyl-p-iodoanilne was resembled the first reaction conditions and the 
desired final product, acetaminophen, had been produced in 66% of isolation 
yield by the assistance of microwave. Under the normal heating system, 47% 




3. Acetaminophen synthesis from p-dihalobenzenes 
 The initial optimized reaction conditions had been reexamed to increase the 
yield of the final product.28 The following scheme shows the optimized 
reaction conditions with PDIB. According to the optimized results, p-
diiodobenzene can be converted to acetaminophen in 55% overall yield via 
















Scheme B8. The acetaminophen synthesis from p-diiodobenzene (PDIB). 
 
Compared to the conventional process of acetaminophen, the newly 
developed two-step process had some advantages. Unlike the conventional 
process, any of the strong acids (H2SO4, and HNO3) were not necessary. That 
implyed the additional process step for the treatment of the waste acids was 
not required any more. In other words, not only the milder reaction conditions 
had been developed for the establishment of the eco-friendly and safe process 
environment, but the overall process also had become simple by changing the 
reaction circumstances. The other defference was the number of steps. 
According to the conventional process, at least 4 to 5 steps were required 
including the separation step to the p-regioisomer, but only two steps were 
necessary in the present process.  
However, the present process showed a limitation, which had not been 




disappointed result with PDIB29 had been reported on copper catalyzed cross 
coupling reactions even though the fundamental reason had not been 
identified yet. Therefore, we considered 4-bromoiodobenzene as an 
alternative potent starting material based on the fact that 4-bromoiodobenzene 
had been applied to the C-N bond cross coupling reaction as a starting 
material and usually showed high yield (80~94%)22 in order to strengthen the 
competitiveness of the two-step process.  
The same synthetic route, which was applied for PDIB (Scheme B9), had 
been reexamined with a new starting material, p-bromoiodobenzen. Before 
starting the optimization of the reactions, we expected better results based on 
the previous results that p-bromoiodobenzen had been more frequently 
applied to amidation reaction and shown better results than PDIB. Moreover, 
that the previously reported results on the hydroxylation of both bromo- and 
iodo-aryl compounds showed the similar yields was also supported our 
expectation for better result with the new starting material. 
Although the optimal conditions had been reported with PDIB26, all of the 
reaction conditions had been screened again. The results of the amidation with 
p-bromoiodobenzene were presented in table B11. First of all, various cupric 
or cuprous catalysts were applied with the previously applied diamine ligands 
for the cross coupling reaction with acetamide. Distinct from the results with 
PDIB, there was chemoselectivity issue with 4-bromoiodobenzene. 
Interestingly, the ratio of N-acetyl-p-bromoaniline to N-acetyl-p-iodoaniline 
was varied depending on the reaction conditions. For example, N-acetyl-p-
bromoaniline was afforded as the sole product when the reaction was 




atmosphere while the mixture of N-acetyl-p-bromoaniline and N-acetyl-p-
iodoaniline was obtained in the pressure tube at the elevated reaction 
temperature (130 oC) although the other reaction conditions were idential. 
However, it was unnecessary to dispute about the chemoselectivity because it 
would not be an issue unless the yields on the hydroxylation of N-acetyl-p-
bromo- and iodo-aniline had a big difference. Fortunately, in the previous 
study with PDIB,28 the yield on the hydroxylation of N-acetyl-p-bromoaniline 
(75%) was approximately equal to that of N-acetyl-p-iodoaniline (74%).28 
Among the examined copper catalysts (Entry 1-10) under the condition A 
where 2.2 equivalent of acetamide and CsF were applied, Cu powder and CuI 
showed highest yields (Entry 1-2) while CuSO4 and Cu(OTf)2  (Entry 9-10) 
showed less effective catalytic reactivities in amidation with N,N’-
dimethylethylene diamine (DMEDA) as the ligand. Interestingly, the tested 
cuprous catalysts (Entry 2-6), such as copper iodide, copper bromide, copper 
cyanide and cuprous oxide, were presented higher yields than the results with 




Table B11. Optimization of the reaction conditions for acetamidation 
Entry Catalyst Ligand Base 
Yield (%)a 
Conditon Ab Condition Bc 
1 Cud  DMEDA CsF 80 93e 
2 CuI DMEDA CsF 82 93e 
3 CuBr DMEDA CsF 73 67f 
4 CuCl DMEDA CsF 72 72e 
5 CuCN DMEDA CsF 79 63 
6 CuTC DMEDA CsF 65 69 
7 Cu2O DMEDA CsF 68 34 
8 CuO DMEDA CsF 77 92f 
9 CuSO4 DMEDA CsF 54 66e 
10 Cu(OTf)2 DMEDA CsF 49 74e 
11 CuI N-Me-EDA CsF 62 -g 
12 CuI EDA CsF 64 - g 
13 CuI CHDA CsF 57 - g 
14 CuI DMCHDA CsF 74 - g 
15 CuI 1,10-
phenanatroline 
CsF 55 - g 
16 CuI DMEDA K3PO4 76 - g 
17 CuI DMEDA KF 32 - g 
18 CuI DMEDA Cs2CO3 91e 92e 
19 CuI DMEDA CsBr 7h - g 
20 CuI DMEDA CsI No rxni - g 
a Isolation yields, which was calculated based on the ratio of N-acetyl-p-iodoaniline and  N-
acetyl-p-bromoaniline, which was measured by 1H NMR.; b 2.2 eq. of acetamide and base 
were applied.; c 4 eq. of acetamide and base were applied.; d Cu powder was applied as a 
catalyst.;  e N-Acetyl-p-bromoaniline was obtained as a sole compound.; f The observed 
selectivity on N-acetyl-p-bromoaniline to N-acetyl-p-iodoaniline was more than 15:1 by 1H 
NMR. ; g The reaction had not been tested.; h 92% of the starting material was recovered.; I  




Interestingly, the improvement of the yield was observed under the condition 
B in which 4.0 equivalents of acetamide and CsF were added except for CuBr, 
CuCN, and Cu2O (Entry 3, 5, and 7). Under the condition B, not only the 
improved results of the desired amidation reaction had been observed, but the 
chemoselectivity in most of reactions also had been changed with affording 
N-acetyl-p-bromoaniline as a single product.  
With the suitable copper catalyst, CuI, well-known diamine ligands (Fig. 
B12) were applied to optimize the reaction conditions. The diamine ligands 
with primary amines (Entry 11-13) less effectively helped the copper catalyst 
compared to the secondary diamine ligands (Entry 2 and 14). trans-
Cyclohexnane-1,2-diamine (CHDA) and 1,10-phenanthroline were appeared 
as insufficient ligands under the acetamidation with the selected copper iodide 
catalyst (Entry 13, 15). The best combination of CuI and DMEDA was 
applied for the rest of the optimization of other reaction conditions, such as 
base and solvent. Surprisingly, Cs2CO3 presented the highest yield and N-
acetyl-p-bromoaniline was afforded as the sole product (Entry 18). While 
K3PO4, which was a commonly used base on C-N bond formation with copper 
catalyst and diamine ligand, showed moderate yield (Entry 16), KF only 
furnished 32% of the desired product (Entry 17). Based on the good results 
with CsF and Cs2CO3, CsBr and CsI were added as the base respectively, but 
the most of the starting material were recovered in both cases (Entry 19-20). 
In order to find a more suitable organic solvent with the other optimized 
reaction conditions, organic solvents having low boiling points had been 
applied, such as ethyl acetate, acetonitrile, and 1,4-dioxane, and it had been 




reason why an organic solvent having low boiling point had been searched 
was for a more advanced process development for acetaminophen, which 
would be discussed at the following section. In summary, the acetamidation of 
p-bromoiodobenzene were optimized with the excess amount of acetamide 
and CsF and the combination of CuI, and DMEDA, or Cu powder with 
DMEDA in THF at 130 oC for 24 h. 
To study the scope of the procedure, the reaction of p-substituted 
halobenzenes with acetamide was examined at the optimal conditions (Table 
B12). Most of examined p-substituted halobenzenes were coupled with 
acetamide to give the desired products in good yields. Iodobenzenes bearing 
various substituted were successfully converted to N-acetylamido-p-
substituted benzenes (Entry 1-7). However, in spite of various efforts to 
improve the yield with p-diiodobenzene, it was not fully converted to the 
desired product where starting material was recovered in 9% at the end of the 
reaction (Entry 1). Interestingly, the amidation of iodophenol (Entry 7), which 
had been considered as an alternative process for the route B in scheme 2, 
quantitatively afforded the desired final product acetaminophen in a step. p-
Substituted bromobenzenes were also successfully converted to the desired 
products, but the lower yield than that of iodobenzenes were observed (Entry 
8-13). 4-Bromonitrobenzene showed the highest yield among the examined 
bromobenzenes (Entry 11) while 4-bromophenol furnished acetaminophen in 
low yield (Entry 13). Low efficiency of acetamidation with p-dichlorobenzene 










CuI (2 mol%), DMEDA (20 mol%)
acetamide, CsF, pressure tube
THF, 130 oC  
Entry R1 R2 Yield % 
1 I I 69 
2 Br I 93 
3 Cl I 99 
4 F I 99 
5 NO2 I 99 
6 MeO I 99 
7 HO I 99 
8 Br Br 57 
9 Cl Br 53 
10 F Br 43 
11 NO2 Br 88 
12 MeO Br 53 
13 HO Br 16 
14 Cl Cl 17 
 
 
establishment of the next hydroxylation step in order to complete the new 
eco-friend process for acetaminophen. Similar to the previous study with 
PDIB, copper catalyst and diamine ligand were employed and the copper 
catalyzed phenol synthesis in water kept explored instead of the mixed solvent 
system with organic solvent, such as dimethylsulfoxide(DMSO). Based on the 




(2), we tried to find more compatible reaction conditions for the hydroxylation 
of N-acetyl-p-bromoaniline (3), which had been tested under the previously 
optimized reaction conditions in the previous study.19 The previous 
microwave reaction conditions were reexamined with N-acetyl-p-
bromoaniline (3), and the final product acetaminophen was obtained in 73% 
yield at the lowered reaction temperature (120 oC) under the same previous 
reaction conditions except for the temperature. Because the better yield was 
observed under the normal heating reaction conditions with pressure tube 
according to our previous study, the reaction conditions were reexamined 
under the normal heating system. The results of the optimization were stated 
in table 3. The selected copper catalysts and diamine ligands, which showed 
better results at the amidation step, were tested. Copper iodide showed the 
highest isolated yield of acetaminophen (Entry 1), and other selected copper 
catalysts also presented good yields (Entry 2-5). In accordance with the ligand 
screening results at the amidation step, DMEDA furnished the best results 
(Entry 1). Among other diamine ligands tested, trans-N,N’-
dimethylcyclohexane diamine (DMCHDA) also showed a pleasing result on 
hydroxylation with water (Entry 8). However, in contrast with the results of 
base screening in the previous amidation step, Cs2CO3 and K3PO4 were 
scarcely afforded the final product (Entry 11, 12) while KF furnishes 
acetaminophen in 77 % yield (Entry 13). CsBr and CsI (Entry 9, 10) did not 
provide any good results in this step again. In summary, the optimal result on 
the hydroxylation was given in water at 160 oC by the combination of CuI, 












Cu cat. (10 mol%), ligand (50 mol%)
base (2 eq.), H2O (6 mL) 
pressure tube, 160 oC, 24 h  
Entry Catalyst Ligand Base Yield % 
1 CuI DMEDA CsF 85 
2 Cu powder DMEDA CsF 80 
3 CuCN DMEDA CsF 65 
4 Cu2O DMEDA CsF 70 
5 CuO DMEDA CsF 70 
6 CuI N-Me-EDA CsF 70 
7 CuI EDA CsF 64 
8 CuI DMCHDA CsF 76 
9 CuI DMEDA CsBr 38 
10 CuI DMEDA CsI 20 
11 CuI DMEDA Cs2CO
3 
Trace 
12 CuI DMEDA K3PO4 Trace 
13 CuI DMEDA KF 77 
 
To study the scope of the established hydroxylation conditions, other 
potential intermediates for acetaminophen, including N-acetyl-p-haloaniline 
and p-substituted halobenzenes, were examined at the optimal reaction 










CuI (10 mol%), DMEDA (50 mol%)
CsF (2 eq.), H2O (6 mL) 
pressure tube, 160 oC, 24 h  
Entry R1 R2 Yield % 
1 I NHAc 78 
2 Br NHAc 85 
3 Cl NHAc 73 
4 F NHAc - 
5 I NH2 45 
6 Br NH2 74 
7 Cl NH2 60 
8 F NH2 - 
9 I NO2 28 
10 Br NO2 29 
11 Cl NO2 14 
12 F NO2 - 
 
Most potent intermediates for acetaminophen, N-acetyl-p-haloanilines (Entry 
1-3), were successfully furnished the desired product in good yield. 
Interestingly, N-acetyl-p-iodoaniline showed lower yield than that of N-acetyl-
p-bromoaniline due to the undesired side reaction, de-halogenation. With N-
acetyl-p-iodoaniline, N-acetylanilinde was obtained in 5% yield. 
 Including the N-acetyl-p-fluoroaniline (Entry 4), all of the examined p-
substituted fluoroaniline remained intact under the copper catalyzed 
hydroxylation (Entry 3, 7, and 11). While p-aminophenol, well-researched 




moderate to good yields (Entry 5-7), p-nitrophenol that was one of precursors 
for p-aminophenol was obtained in low yields from p-nitrohalobenzene. 
In summary, acetaminophen had been efficiently synthesized in 79% yield 
from p-bromoiodobenzene via the suggested two-step process. The two-step 
process was consisted with two copper catalyzed cross coupling reactions 
between the dihalobezene and acetamide or water, and the each of the reaction 
conditions was resemble each other.  From that point, we planned to simplify 
the established two-step process. We expected that the two-step process could 






4. A New one-pot process for acetaminophen 
 Based on the extensive screening results on acetamidation and hydroxylation 
with p-dihalobenzens, the optimized two-step process was changed to be 
suitable for the new purpose. The first thing to accomplish the one-pot process 
was to make each of the reaction conditions in the two-step process similar. 
Among the optimal bases (CsF and Cs2CO3) at the amidation step, CsF was 
selected because Cs2CO3 did not produce acetaminophen under the copper 
catalyzed hydroxylation conditions with water. Therefore, the determined 
reagents for the one-pot process were CsF and the combination of CuI and 
DMEDA as base, catalyst and its ligand.  
First, we hypothesized that the hydroxylation would be progressed by the 
addition of water to the condensed reaction mixture, which was readily 
prepared by the removal of the solvent right after the amidation reaction was 
completed. However, the desired a was obtained only in 44% yield with the 
mixture of N-acetyl-p-bromoiodobenzene and acetanilide. The prolonged 
reaction time (48 h) at the hydroxylation step did also provide the same result 
(46% isolation yield). From these disappointed results, we assumed that the 
loss of diamine ligand could be accompanied with the removal of solvent, so 
the additional DMEDA (0.2 equiv.) was applied when the water was added to 
the condensed reaction mixture. As the result of it, acetaminophen was 
synthesized in the improved yield (57%), but the new one-pot process did not 
seem to be efficient as much as the established two-step process due to the 
low yield. Therefore, we tried the hydroxylation without any treatments 
except for the addition of water to the reaction mixture right after the 




p-aminophenol had been increased to 74%, which was the similar result with 
that from the two-step process (79%) under the condition B in table B11. 





CuI (2 mol%), L1 (20 mol%)
acetamide (1.05 eq.), CsF (4 eq.) 
pressure tube, THF, 130 oC, 24 h;
then, H2O (6 mL), 160 oC, 24 h  
Entry R1 R2 
Yield (%) 
One-pot Two-pot 
1 Br I 74 79 
2 Br Br 50 48 
3 Br Cl 37a 42 
4 I Cl 38b 72 
5 I I 35c 54 
a. 32% of N-acetyl-p-chloroaniline was obtained.; 
b. 24% of N-acetyl-p-chloroaniline was obtained.; 
c. 13% of N-acetyl-p-iodoniline was obtained. 
 
The simplified one-pot procedure was examined with p-dihalobenzens for 
the scope of the new procedure. The results of the sequential amidation and 
hydroxylation without the interval purification step were stated in table B15 
with the results from the two-step process. p-Dibromobenzene and p-
bromochlorobenzene were converted to the desired N-acetyl-p-aminophenol 
in 50% and 37% yield (Entry 2-3), which were the almost same results from 
two-step process. However, the results from one-pot procedure with p-
chloroiodobenzene (Entry 4) or p-diiodobenzene (PDIB, Entry 5) did not 
reach to the results from two-step process as affording the N-acetyl-p-




5. Acetaminophen production via the Cu-catalyzed process 
  
p-Diiodobenzene was successfully converted to the desired acetaminophen via 
the suggested two Cu-catalyzed reactions (Scheme B8). Under the optimized 
reaction conditions in normal heating system, each Cu-catalyzed reaction 
afforded the desired products in 74% yields, respectively.  
In order to check whether the new process could be applied as an industrial 
process, the acetamidation was performed with 10 mmol of p-diiodobenzene 
in autoclave instead of the pressure tube (Scheme B9). The desired N-acetyl-
p-iodobenzene was synthesized in 53% yield with 31% of starting material 
recovery. The hydroxylation also conducted at the same scale (10 mmol) to 
produce the desired acetaminophen, and the desired analgesic was produced 














160 oC, 66%10 mmol  
Scheme B9. Acetaminophen production via Cu-catalyzed process. 
 
Although the starting materials were remained in large-scale, the overall 
yield based on the starting material recovery was 50%, which was similar to 
the result in small scale. Because the remained starting material could be 
recycled or recovered, the developed Cu-catalyzed process was considered as 
a suitable industrial process for acetaminophen. 




because the new process required a relatively expensive startimg material, p-
diiodobenzene. In the conventional process for acetaminophen, phenol or 
chlorobenzene was used as the starting material. However, the issue could be 
solved by the recovery of iodine from the resulting mixture after the 
reactions.30 According to the previous study on the phenylenediamine 
production from p-diiodobenzene, iodide salts from the reaction mixture were 
recovered with H2O2 and recycled to produce p-diiodobenzene, and the yield 
of the recovered iodine was 98%. 
 
 






It had been developed that a practical and efficient process for 
acetaminophen from p-dihalobenzenes. The developed process does not only 
allow eco-friend reaction environments via the inexpensive copper catalyzed 
reactions but also solve the conventional issues on acetaminophen production 
including the formation of regio-isomers and the inevitable process steps, 
such as the waste acids treatment step, and a separation step for the desired p-
regioisomers. From the established two-step process, p-bromoiodobenzene 
was successfully converted to N-acetyl-p-aminophenol in 79% yield. 
Furthermore, the two-step process was simplified to the one-pot process for 
more practical and economical process. The simplified one-pot process also 









General Procedure. All reactions were carried out in oven-dried pressure 
tube with magnetic stirring. All materials were obtained from commercial 
sources and were used without further purification. Reaction solvents, 
tetrahydrofuran and distilled water, were sparged with argon prior to use. The 
reactions were monitored with a SiO2 TLC plate under UV light (254 nm). 
Column chromatography was performed on silica gel 60 (70-230 mesh). 
Melting points were measured on a Meltemp apparatus in open capillary tubes. 
1H and 13C NMR spectra were measured at 400 MHz and 100 MHz, 
respectively in DMSO-d6 with Bruker Avance-400 unless stated otherwise. 
The 1H NMR spectroscopic data were reported as follows in ppm (δ) from the 
2.5 resonance of DMSO-d6: chemical shift (multiplicity, integration, coupling 
constant in Hz). The 13C NMR spectra data were referenced with the 39.51 
resonance of DMSO-d6. Low and high resolution mass spectra were measured 
by the FAB ionization method and analyzed by magnetic sector mass analyzer. 
 
General procedure for amidation of p-substituted halobenzenes with 
acetamide under Condition A 
To a pressure tube which was backfilled with N2 p-dihalobenzenes or p-
substituted halobenzene, (1 mmol), acetamide (236 mg, 4.0 mmol), CsF (608 
mg, 4.0 mmol) and CuI (3.8 mg, 0.02 mmol) were added, and then the 




was sealed carefully right after the addition of N,N’-dimethylethylenediamine 
(DMEDA, 22 µL, 0.2 mmol). The sealed pressure tube was heated to 130 oC 
and vigorously stirred for 24 h. After cooling back to room temperature, the 
mixture was diluted with EtOAc (20 mL), and an aqueous saturated solution 
of NaCl (20 mL) was added to the mixture. The resulting mixture was 
separated and the aqueous layer was extracted with EtOAc (20 mL×3). The 
combined organic layers were dried over MgSO4, filtered and concentrated 
under the reduced pressure. The obtained organic residue was purified by 
silica gel chromatography (hexane/EtOAc=2:1) to afford the desired N-acetyl-
p-haloaniline or N-acetyl-p-substituted aniline.   
N-(4-Iodophenyl)acetamide  
; white solid; mp 185~186 oC (lit.22 182~184 oC); 69% (from p-
diiodobenzene); 1H NMR (400 MHz, DMSO-d6) δ 2.03 (s, 3H), 7.41 (d, 2H, 
J=8.8), 7.61 (d, 2H, J=8.8), 10.02 (s, 1H); 13C NMR (100 MHz, DMSO-d6) 
δ 24.0, 86.2, 121.1, 137.2, 139.1, 168.4. HRMS (FAB) calcd for C8H8INO 
261.9729 ([M+H]+), found 261.9723. 
 N-(4-Bromophenyl)acetamide 
; white solid; mp 168~170 oC (lit.23 166~167 oC); 93% (from p-
bromoiodobenzene); 1H NMR (400 MHz, DMSO-d6) δ 2.04 (s, 3H), 7.46 (d, 
2H, J=9.0), 7.55 (d, 2H, J=9.2), 10.05 (s, 1H); 13C NMR (100 MHz, DMSO-
d6) δ 24.0, 114.4, 120.8, 131.4, 138.6, 168.4. HRMS (FAB) calcd for 





; brown solid; mp 153~154 oC (lit.24 152 oC); 99% (from p-
fluoroiodobenzene); 1H NMR (400 MHz, DMSO-d6) δ 2.03 (s, 3H), 7.10 (t, 
2H, J=9.2), 7.59 (dd, 2H, J=5.2, 9.2), 10.00 (s, 1H); 13C NMR (100 MHz, 
DMSO-d6) δ 23.8, 115.1 (d, J=22.0), 120.7 (d, J=7.0), 135.7 (d, J=2.0), 157.8 
(d, J=237); HRMS (FAB) calcd for C8H8FNO 154.0668 ([M+H]+), found 
154.0665. 
N-(4-Nitrophenyl)acetamide 
; yellow solid; mp 215~216 oC (lit.23 215~216 oC); 99% (from p-
nitroiodobenzene); 1H NMR (400 MHz, DMSO-d6) δ 2.12 (s, 3H), 7.82 (d, 
2H, J=9.2), 8.21 (d, 2H, J=9.2), 10.57 (s, 1H); 13C NMR (100 MHz, DMSO-
d6) δ 24.1, 118.5, 124.8, 142.0, 145.4, 169.3; HRMS (FAB) calcd for 
C8H8N2O3 181.0613 ([M+H]+), found 181.0618. 
N-(4-Methoxyphenyl)acetamide 
; white solid; mp 127~128 oC (lit.23 128~130 oC); 99% (from p-iodoanisole); 
1H NMR (400 MHz, DMSO-d6) δ1.99 (s, 3H), 3.71 (s, 3H), 6.85 (d, 2H, 
J=9.2), 7.46 (d, 2H, J=9.2), 9.76 (s, 1H); 13C NMR (100 MHz, DMSO-d6) δ 
23.7, 55.1, 113.8, 120.6, 132.6, 155.1, 167.8; HRMS (FAB) calcd for 
C9H11NO2 166.0868 ([M+H]+), found 166.0873. 
General procedure hydroxylation of N-acetyl-p-halobenzene 
To a pressure tube backfilled with N2, N-acetyl-p-halobenzene (1 mmol), CsF 




immediately sparged H2O (6 mL) was added to the pressure tube. The tube 
was sealed carefully right after the addition of DMEDA (54 L, 0.5 mmol). 
The sealed pressure tube was heated to 160 oC and vigorously stirred for 24 h. 
After the cooling back to the room temperature, the mixture was diluted with 
EtOAc (20 mL) and then the aqueous layer was saturated with NH4Cl salt. 
The resulting mixture was separated and the aqueous layer was extracted with 
EtOAc (20 mL×4). The combined organic layers were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The organic residue was 
purified by silica gel chromatography (hexane/EtOAc = 1:4) to afford the 
desired acetaminophen. 
N-(4-Hydroxyphenyl)acetamide 
; white solid; mp 168~170 oC (lit.23 166~167 oC); 78% (from N-(4-
iodophenyl)acetamide); 1H NMR (400 MHz, DMSO-d6) δ 1.99 (s, 3H), 6.69 
(d, 2H, J=9.0), 7.35 (d, 2H, J=9.0), 9.12 (s, 1H), 9.63 (s, 1H); 13C NMR (100 
MHz, DMSO-d6) δ 23.7, 115.0, 120.9, 131.0, 153.2, 167.6; HRMS (FAB) 
calcd for C8H9NO2 152.0712 ([M+H]+), found 152.0714. 
 
General procedure for one-pot procedure for aetaminophen from p-
dihalobenzen 
To a pressure tube which was backfilled with N2, p-dihalobenzenes (1 mmol), 
acetamide (62 mg, 1.05 mmol), CsF (304 mg, 2.0 mmol) and CuI (3.8 mg, 
0.02 mmol) were added, and then the immediately sparged THF (4 mL) was 
added to the pressure tube. The tube was sealed carefully right after the 
addition of DMEDA (22 µL, 0.2 mmol). The sealed pressure tube was heated 




temperature, the sparged H2O (6 mL) was added to the reaction mixture. The 
tube was sealed carefully, and the sealed pressure tube reacted at 160 oC with 
vigorous stirring for 24 h. After the cooling back to the room temperature, the 
mixture was diluted with EtOAc (20 mL) and then the aqueous layer was 
saturated with NH4Cl salt. The resulting mixture was separated and the 
aqueous layer was extracted with EtOAc (20 mL×4). The combined organic 
layers were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The organic residue was purified by silica gel chromatography 






1. Sardina F.J.; Rapoport H., Enantiospecific synthesis of heterocycles from 
a-amino acids, Chem. Rev. 1996, 96, 1825 and references therein  
2. (a) Garner, P.; Park, J.M., The synthesis and configurational stability of 
differentially protected β-hydroxy-a-amino aldehydes, J. Org. Chem. 
1987, 52, 2361. (b) Falorni, M.; Conti, S.; Giacomelli, G.; Cossu, S.; 
Soccolini, F., Optically active 4-oxaroline derivatives: New useful chiral 
synthons derived from serin and threonine, Tetradedron: Asymmetry, 1995, 
6, 287. (c) Lubell, W.D.; Rapoport, H., Configurational stability of N-
protected a-amino aldehydes, J. Am. Chem. Soc. 1987, 109, 236. (d) Reetz, 
M.T., New approaches to the use of amino acids as chiral building blocks 
in organic synthesis, Angew. Chem., Int. Ed. 1991, 30, 1531. 
3. Ito, A.; Takahshi, R.; Baba, Y., A new method to synthesize a-
aminoaldehydes, Chem. Pharm. Bull. 1975, 23, 3081. 
4. (a) Hyun, S.I.; Kim, Y.G., N-Hydroxymethyl group for configurationally 
stable N-alkoxycarbonyl a-amino aldehydes, Tetrahedron Lett. 1998, 39, 
4299. (b) Yoo, D.; Oh, J. S.; Lee, D.-W.; Kim, Y. G., Efficient synthesis 
of a configurationally stable L-serinal derivative, J. Org. Chem. 2003, 68, 
2979.  
5. von Nussbaum, F.; Analuf, S.; Freiburg, C.; Benet-Buchholz, J.; 
Schamberger, J.; Henkel, T.; Schiffer, G..; Habich, D., Total synthesis and 
initial structure-activity relationships of Longicatenamycin A, Chem. Med. 




6. Yoo, D.; Oh, J. S.; Kim, Y. G., The N-hydroxymethyl group for 
stereoselective conjugation addition: Application to the synthesis of (-)-
statine, Org. Lett. 2002, 4, 1213.  
7. Yoo, D.; Kwon, S.; Kim, Y. G., Application of the N-hydroxymethyl 
group to the stereoselective synthesis of (3S,4S)-3-aminodeoxystatine 
derivatives, Tetrahedron: Asymmetry 2005, 16, 3762. 
8. Yoo, D.; Kim, H.; Kim, Y. G., Intramolecular nucleophilic epoxidation of 
g-amino-a,β-unsaturated esters with an N-hydroxymethyl group, Synlett. 
2005, 1707. 
9. Yoo, D.; Song, J.; Kang, M. S.; Kang, E.; Kim, Y. G., Efficient and 
stereoselective synthesis of threo-β-hydroxy-L-glutamic acid via a tandem 
(Z)-olefination-conjugate addition, Terahedron: Asymmetry 2011, 22, 
1700. 
10.  Kim, H.; Yoo, D.; Kwon, S.; Kim, Y. G., Stereodivergent approach to 
both syn- and anti-isomers of g-amino-β-hydroxy acids: (3S,4S)- and 
(3R,4S)-AHPPA derivatives, Tetrahedron: Asymmetry 2009, 20, 2715. 
11.  (a) Bergmeier, S. C., The synthesis of vicinal amino alcohols, 
Tetrahedron 2000, 56, 2561. (b) Bauvois, B.; Dauzonne, D., 
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological 
evaluations and therapeutic prospects, Med. Res. Rev. 2006, 26, 88. (c) 
Luan, Y.; Mu, J.; Xu, W., The review of the synthesis of bestatin, an 
effective inhibitor of aminopeptidase N, Mini-Rev. Org. Chem. 2008, 5, 
134. 
12.  (a) Bergmeier, S. C.; Stanchina, D. M., Acylnitrene route to vicinal 




J. Org. Chem. 1999, 64, 2852. (b) Nemoto, H.; Ma, R.; Suzuki, I.; Shibuya, 
M., A new one-pot method for the synthesis of a-siloxyamides from 
aldehydes or ketones and its application to the synthesis of (-)-bestatin, 
Org. Lett. 2000, 2, 4245 (c) Lee, B. W.; Lee, J. H.; Jang, K. C.; Kang, J. 
E.; Kim, J. H.; Park, K.-M.; Park, K. H., Diastereoselective synthesis of 
syn-aminoalcohols via contributing CH-π interaction: simple synthesis of 
(-)-bestatin, Tetrahedron Lett. 2003, 44, 5905. (d) Kudyba, I.; Raczko, J.; 
Jurczak, J., Asymmetric nitroaldol reaction. Synthesis of Taxotere side 
chain and (-)-bestatin using (1R)-8-phenylmethyl glyoxylate, J. Org. Chem. 
2004, 69, 2844.  (e) Feske, B. D., Bestatin: Three decades of synthetic 
strategies, Curr. Org. Chem. 2007, 11, 483. 
13.  Tobe, H.; Morishima, H.; Aoyagi, T.; Umezawa, H.; Ishiki, K.; 
Nakamura, K.; Yoshioka, T.; Shimauchi, Y.; Inui, T., Synthesis and 
structure-activity relationships of amastatin analogues inhibitors of 
aminopeptidase A, Agric. Biol. Chem. 1982, 46, 1865. 
14.  Shimamoto, K., Glutamate transporter blockers for elucidation of the 
function of exicitatory neurotransmission systems, Chem. Rec. 2008, 8, 
182. 
15.  (a) Nicolaou, K. C.; Dai, W.-M.; Guy, R. K., Chemistry and biology of 
Taxol, Angew. Chem. Int. Ed. 1994, 33, 15. (b) Borah, J. C.; Gogoi, S.; 
Boruwa, J.; Kalita, B.; Barua, N. C., A highly efficient synthesis of the C-
13 side-chain of taxol using Shibasaki’s asymmetric Henry reaction, 
Tetrahedron Lett. 2004, 45, 3689. 
16.  (a)  Ager, D. J.; Prakash, I.; Schaad, D. R., 1,2-Amino alcohols and their 




Chem. Rev. 1996, 96, 835. (b) Ager, D. J.; Prakash, I.; Schaad, D. R., 
Chiral oxazolidinones in asymmetric synthesis, Aldrichimica Acta 1997, 
30, 3. 
17.  (a) Rubin, A. E.; Sharpless, K. B., A highly efficient aminohydroxylation 
process, Angew. Chem. Int. Ed. Engl. 1997, 36, 2637. (b) O’ Brien, P., 
Sharpless asymmetric aminohydroxylation: scope, limitations and use in 
synthesis, Angew. Chem. Int. Ed. 1999, 38, 326. (c) Donohoe, T. J.; 
Johnson, P. D.; Pye, R. J., The tethered aminohydroxylation (TA) reaction, 
Org. Biomol. Chem. 2003, 1, 2025. (d) Abraham, E.; Davis, S. G.; 
Millican, N. L.; Nicholson, R. L.; Roberts, P. M.; Smith, A. D., 
Asymmtric synthesis of vicinal amino alcohols: xestoaminol C, 
sphinganine and sphingosine, Org. Biomol. Chem. 2008, 6, 1655. 
18.  (a) Dou, D.-M.; Liu, Y.-C.; Chen, C.-S., A practical chemoenzymatic 
synthesis of the Taxol C-13 side chain N-benzoyl-(2R,3S)-3-
phenylisoserine, J. Org. Chem. 1993, 58, 1287-1289. (b) Pastó, M.; 
Castejón, P.; Moyano, A.; Pericàs, M. A.; Riera, A., A catalytic 
asymmetric synthesis of cyclohexylnorstatine, J. Org. Chem. 1996, 61, 
6033. (c) Tosaki, S.-Y.; Tsuji, R.; Ohshima, T.; Shibasaki, M., Dynamic 
ligand exchange of the lanthanide complex leading to structural and 
functional transformation: One-pot sequential catalytic asymmetric 
epoxidation-regioselective epoxide-opening process, J. Am. Chem. Soc. 
2005, 127, 2147. 
19.  (a) Matsunaga, S.; Yoshida, T.; Morimoto, H.; Kumagai, N.; Shibasaki, 
M., Direct catalytic asymmetric Mannich-type reaction of hydroxyketone 




amino alcohols, J. Am. Chem. Soc. 2004, 126, 8777. (b) Dziedzic, P.; 
Schyman, P.; Kullberg, M.; Córdova, A., Highly enantioselective 
organocatalytic addition of aldehydes to N-(phenylmethylene)benzamides: 
Asymmetric synthesis of the paclitaxel side chain and its analogues, Chem. 
Eur. J. 2009, 15, 4044. (c) Gassa, F.; Contini, A.; Fontana, G.; Pellegrino, 
S.; Gelmi, M. L., A highly diastereoselective synthesis of a-hydroxy-β-
amino acid derivatives via a Lewis acid catalyzed three-component 
condensation reaction, J. Org. Chem. 2010, 75, 7099. 
20.  Ballini, R.; Petrini, M., Recent synthetic developments in the nitro to 
carbonyl conversion (Nef reaction), Tetrahedron 2004, 60, 1017, and 
references therein. 
21.  Suzuki, T.; Honda, Y.; Izawa, K.; Williams, R. M., Remarkable 
diastereomeric rearrangement of an a-acyloxy β-ketosulfide to an a-
acyloxy thioester: A novel approach to the synthesis of optically active 
(2S,3S)-β-amino-a-hydroxy acids, J. Org. Chem. 2005, 70, 7317, and 
references therein 
22.  Rein, T.; Reiser, O., Recent advances in asymmetric Wittig-type 
reactions, Acta Chem. Scand. 1996, 50, 369, and references therein. 
23.  Standen, L. F. ; Gravestock, D.; Ager, D., New developments in the 
Peterson olefination reaction, J. Chem. Soc. Rev. 2002, 31, 195., and 
references therein. 
24.  Luzzio, F. A., The Henry reaction: recent examples, Tetrahedron 2001, 
57, 915., and references therein. 
25.  (a) Ambroise, L.; Jackson, R. F. W., Stereoselective synthesis of anti-β-




arylthio-1-nitroalkenes, Tetrahedron Lett. 1996, 37, 2311. (b) Wade, P. 
A.; Murray, Jr. J. K.; Shah-Patel, S.; Palfey, B. A.; Caroll, P. J., Tandem 
nitroaldol-dehydration reactions employing the dianion of 
phenylsulfonylnitromethane, J. Org. Chem. 2000, 65, 7723. (c) Concellón, 
J. M.; Rodríguez-Solla, H.; Concellón, C., Efficient nitro-aldol reaction 
using SmI2: A new route to nitroalcohols under very mild conditions, J. 
Org. Chem. 2006, 71, 7919. 
26.  Other reagents examined for the oxidation of the phenylsulfonyl-
nitromethyl group included TiCl3, AcOH/NaNO2, and SnCl2. Trost, B. M.; 
Madsen, R.; Guile, S. D.; Brown, B., Palladium-catalyzed enantioselective 
synthesis of carbanucleosides,  J. Am. Chem. Soc. 2000, 122, 5947. 
27.  (a) Andrés, J. M.; Martínez, M. A.; Pedrosa, R.; Pérez-Encabo, A., 
Stereoselective cyanation of chiral a-amino aldehydes by reaction with 
Nagata’s reagent: a route to enantiopure β-amino-a-hydroxy acids, 
Tetrahedron: Asymmetry 2001, 12, 347. (b) Tasić, G.; Matović, R.; Saičić, 
R. N., Stereoselective synthesis of a-hydroxy-β-amino acids: the chiral, J. 
Serb. Chem. Soc. 2004, 69, 981. 
28.  (a) Hirama, M.; Hioki, H.; Ito, S., New entry to syn-β-hydroxy-a-amino 
acids, Tetrahedron Lett. 1988, 29, 3125. (b) Hoffmann, R. W., Allylic 1,3-
strain as a controlling factor in stereoselective transformations, Chem. Rev. 
1989, 89, 1841. 
29.  (a) Tobe, H.; Morishima, H.; Naganawa, H.; Takita, T.; Aoyagi, T.; 
Umezawa, H., Structure and chemical synthesis of amastatin, Agric. Biol. 
Chem. 1979, 43, 591. (b) Martín-Zamora, E.; Ferrete, A.; Llera, J. M.; 




on stereoselective [2+2] cycloadditions between N,N-dialkylhydrazones 
and ketenes, Chem. Eur. J. 2004, 10, 6111. 
30. Scornik O A, Botbol V, Curr. Drug Metab, 2001, 2, 67. 
31. Harbut B, M.; Velmourougane, G.; Reiss, G.; Chandramohanadas, R.; 
Greenbaum, D. C., Development of bestatin-based activity-based probes 
for metallo-aminopeptidases, Bioorg. Med. Chem. Lett. 2008, 18, 5932. 
32.  Chae, D.-W., Efficient synthesis of (-)-bestatin and its analogs via novel 
derivatives of 3-amino-2-hydroxy-4-phenylbutanoic acid, Dissertation, 
Seoul National Univeristy, 2013.  
33.  Chung, M.-C.; Lee, H.-J.; Chun, H.-K.; Lee, C.-H.; Kim, S.-I.; Kho, Y.-
H., Bestatin analogue from Streptomyces neyagawaensis SL-387, Biosci. 
Biotech. Biochem. 1996, 60, 898. 
34. (a) Ozawa, S.; Kamiya, H.; Tsuzuki, K., Glutamate receptors in the 
mammalian central nervous system, Prog. Neurobiol., 1998, 54, 581. (b) 
Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F., The glutamate 
receptor ion channels, Pharmacol. Rev., 1999, 51, 7. (c) Sattler, R.; 
Tymianski, M., Molecular mechanism of glutamate recptor-mediated 
excitotoxic neuronal cell death, Mol. Neurobiol., 2001, 24, 107. (d) 
Danbolt, N.C., Glutamate uptake, Prog. Neurobiol., 2001, 65, 1.  
35.  Keiko, S., Glutamate transporter blockers for elucidation of the function 
of excitatory neurotransmission systems, Chem. Rec. 2008, 8, 182. 
36.  Johnston, G.A.; Lodge, D.; Bornstein, J. C.; Curtis, D.R., Potentiation of 
L-glutamate and L-aspartate exciation of cat spinal neurones by the 




37.  Coleman, R.S.; Carpenter, A.J., Diastereoselective addition of vinyl 
organometallic reagents to L-serinal, Tetrahedron Lett. 1992, 33, 1697. 
38. Dvorzhak, A.; Unichenko, P.; Kirischuk, S. Glutamate transporters and 
presynaptic metabotropic glutamate receptors protect neocortical Cajal-
Retzius cells against over-excitation. Pflugers Arch., 2012, 464, 217.   
39. Shimamoto, K.; Lebrun, B.; Yasuda-Kamatani, Y.; Sakaitani, M.; Shigeri, 
Y.; Yumoto, N.; Nakajima, T., DL-threo-β-Benzyloxyaspartate, a potent 
blocker of excitatory amino acid transporters, Mol. Pharmacol., 1998, 53, 
195. 
40. Shimamoto, K.; Shigeri, Y.; Yasuda-Kamatani, Y.; Lebrun, B.; Yumoto, 
N.; Nakajima, T., Syntheses of optically pure β-hydroxyaspartate 
derivatives as glutamate transpoerter Blockers, Bio. Med. Chem. Lett., 
2000, 10, 2407. 
41.  Nicolaou, K. C.; Li, H.; Boddy, C. N. C.; Ramanjulu, J. M.; Yue, T.-Y.; 
Natarajan, S.; Chu, X.-J.; Bräse, S.; Rübsam, F., Total synthesis of 
Vancomycin-Part 1:Design and development of methodology, Chem. Eur. 
J. 1999, 5, 2584. 
42. Lampret, B.R.; Kidrič, J.; Kralj, B.; Vital, L.; Kokorny, M.; Renko, M. , 
Lapstatin, a new aminopeptidase inhibitor produced by Streptomye, 
rimosus, inhibits autogenous aminoepetidases, Arch. Microbiol. 1999, 171, 
397. 
43. Seo, W. D.; Cutis-Long, M. J.; Ryu, Y. B.; Lee, J. H.; Yang, M. S.; Lee, 
W. S.; Park, K. H., Highly diastereoselective epimerization: 
Stereodivergent synthesis of a-hydroxy-β-amino isopentanoic acid, J. Org. 





1. Friderichs, E.; Christoph, T.; Buschmann, H. Analgesics and antipyretics, 
Ullmann’s Encyclopedia of Industrial Chemistry, John Wiley & Sons: 
New York, NY, 2007, 8-9. 
2. Chan, A.; Hepp, P. Centralbl. Klein Med. 1886, 7, 561. 
3. Morse, H. N. Ber. Deutscher Chem. Ges. 1878, 11, 232. 
4. Jὀẑwiak-Bebenista, M.; Nowak, J. Z., Paracetamol: Mechanism of action, 
applications and safety concern, Acta. Pol. Pharm. 2014, 71, 11. 
5. Von Mering, J. Ther. Monatsch. 1893, 7, 577. 
6. Howard, S. S. Pain Physician, 2009, 12, 269. 
7. Dal Pan, G. J., Acetaminophen: Background and Overview, US Food and 
Drug Administration, www.fda.gov, 2009, June, 29. 
8. Shin, Y. W.; Yoon, S. Y.; Jung, M. J.; Lee, S. W. 2012 Analytic Reports 
on pharmacological industry, 2012, Korea Health Industry Development 
Institute 
9. p-Aminophenol (a) Mitchell, S. C.; Waring, R., Aminophenol, Kirk-
Othmer Encylcopedia of Chemical Technology, John Wiley & Sons: New 
York, NY, 2003, 652. (b) Mitchell, S. C.; Waring, R. H. Ullmann’s 
Encyclopedia of Industrial Chemistry, John Wiley & Sons: New York, NY, 
2012, 58. 
10. (a) Warner-Lambert, Process of preparing N-acetyl-p-aminophenol, US 
Patent 2 998 450, 1961. (b) Kleemann, A.; Engel, J.; Kutscher, B.; 
Reichert, D. Pharmaceutical Substances, Synthesis, Patents, Applications, 




11. Fris and Bechmann rearrangement (a) Davenport, K.G.; Hilton, C.B., 
Process for production N-acyl-hydroxy aromatic amines, US Patent 4 524 
217, 1985. (b) Ghiaci, M.; Aghaei, H.; Oroojeni, M.; Aghabarari, B.; 
Rives, V.; Vicente, M.A.; Sobrados, I., Sanz, J., Synthesis of paracetamol 
by liquid phase Beckmann rearrangement of 4-hydroxyacetophenone 
oxime over H3PO4/Al-MCM-41, Catal. Commun. 2009, 10, 1486. (c) 
Chung, Y.-M.; Rhee, H.-H., Solvent effects in the liquid phase Beckmann 
rearrangement of 4-hydroxyacetophenon oxime over H-Beta catalyst, ,J. 
Mol. Catal. A.: Chem. 2000, 19, 389. (d) Quartarone, G.; Rancan, E.; 
Ronchin, L.; Vavasori, A., Beckmann rearrangement of actophenone 
oximes to the corresponding amides organo-catalyzed by trifluoroacetic 
acid for sustainable NSAIDs synthesis, Appl. Catal., A. 2014, 472, 167. 
12. Bamberger rearrangement (a) Caskey, D.C.; Chapman, D.W., Process for 
preparating p-aminophenol and alkylsubstituted p-aminophenol, US Patent, 
4 571 437, 1986. (b) Rode, C. V.; Vaidya, V.; Chaudhari, R. V., Synthesis 
of p-aminophenol by catalytic hydrogenation of nitrobenzene, Org. Pro. 
Res. Dev. 1999, 3, 465. (c) Rode, C. V.; Vaidya, M. J.; Jaganathan, R.; 
Chaudhari, R. V., Hydrogenation of nitrobenzene to p-aminophenol in a 
four-phase reactor kinetics and mass trarnsfer effects, Chem. Eng. Sci. 
2001, 56, 1299. (d) Nadgeri, J.M.; Biradar, N.S.; Patil, P.B.; Jadkar, S.T.; 
Garade, A.C.; Rode, C.V., Control of competing hydrogenation of 
phenylhydroxylamine to aniline in a single-step hydrogenation of 




13. (a) Tolstoouhov, A. T., Preparation of N-Aryl amides, US patent, 2 013 
394, 1935. (b) Baron, F. A.; Hills, S., Method of purification of N-acetyl-
p-aminophenol, US patent, 3 748 358, 1973. 
14. (a) Frelfelder, M.; Ill, W., Process for the preparation of 
acetylaminophenols, US patent, 3 076 030, 1963. (b) Duessel, B.F.; 
Wilbert, G., Process for the preparation of N-acetyl-p-aminophenol 
(APAP), US patent, 3 341 587, 1967. 
15. Keel, B.L.; Klaus, I.S.; Oftedahl, M.L., Purification of N-
acetylaminophenols, US patent, 4 474 985, 1984. 
16. Snead, D. R.; Jamison, T. F., A Three-Minute synthesis and Purification 
of Ibuprofen: Pushing the Limits of Continuous-Flow Processing, Angew. 
Chem. Int. Ed., 2014, 53, 1. 
17. Kim, H.-S.; Cha, I.-H.; Lim, J.-B. Production of ary iodinated compounds, 
KR 10-2007-0132303, 2007. 
18. Ullmann, F.; Sponagel, P. Ber. Dtsch. Chem. Ges. 1905, 38, 2211. 
19. Goldberg, I. Ber. Dtsch. Chem. Ges. 1906, 39, 1691. 
20. Evano, G.; Blanchard, N.; Toumi, M., Copper-mediated coupling 
reactions and their applications in natural products and designed 
biomolecules synthesis, Chem. Rev. 2008, 108, 3054. 
21. (a) Ma, D.; Zhang, Y.; Yao, J.; Wu, S.; Tao, F., Accelerating effect 
induced by the structure of a-amino acid in the copper-catalyzed couling 
reaction of ary halides with a-amino acids. Synthesis of benzolactam-V8, 
J. Am. Chem. Soc. 1998, 120, 12459. (b) MA, D.; Xia, C., CuI-catalyzed 
coupling reaction of β-amino acids or esters with aryl halides at 




Facile synthesis of SB-214857, Org. Lett, 2001, 3, 2583. (c) Job, G. E.; 
Buchwald, S. L., Copper-catalyzed arylation of β-amino alcohols, Org. 
Chem. 2002, 4, 3703. 
22. (a) Deng, W.; Wang, Y.-F.; Zou, Y.; Liu, L.; Guo, Q.-X., Amino acid-
mediated Goldberg reactions between amids and aryl iodides, Tetrahedron 
Lett. 2004, 45, 2311. (b) Hosseinzadeh, R.; Tajbakhsh, M; Mohadjerani, 
M.; Megdinejad, H., Copper-catalyzed amidation of aryl iodides using 
KF/Al2O3:An Improved Protocol, Synlett. 2004, 1517. (c) Rao, H.; Jin, y.; 
Fu, H.; Jiang, Y.; Zhao, Y., A versatile and efficient ligand for copper-
catalyzed formation of C-N, C-O, and P-C bond: Pyrrolidine-2-
phosphonic acid phenyl monoester, Chem Eur J. 2006, 12, 3636. (d) Lv. 
X.; Bao, W., A β-keto ester as a novel, efficient and versatile ligand for 
copper (I)-catalyzed C-N, C-O and C-S coupling reactions, J. Org. Chem. 
2007, 72, 3863. (e) Quan, Z.-J.; Xia, H.-D.; Zhang, Z.; Da, Y.-X.; Wang, 
X.-C., An efficient copper-catalyzed N-arylation of amides: synthesis of 
N-arylacrylamides and 4-amido-N-phenylbenzamides, Tetrahedron, 2013, 
69, 8368. (f) Mitra, A. W.; Hansen, M. M.; Laurila, M. E.; Kolis, S. P.; 
Martinelli, J. R., a-Aminoamides as ligands in Goldberg amidations,  
Tetrahedron Lett. 2013, 54, 6580. (g) Quan, Z.-J.; Xia, H.-D.; Zhang, Z.; 
Da, Y.-X.; Wang, X.-C., Ligand-free CuTC-catalyzed N-arylation of 
amides, anilines and 4-aminoantipyrine: synthesis of N-arylacrylamides, 4-
amido-N-phenylbenzamides and 4-amino(N-phenyl)antipyrenes, Appl. 
Organometal. Chem. 2014, 28, 81-85. 
23. (a) Wolter, M.; Nordmann, G.; Job, G. E.; Buchwald, S. L., Copper-




4, 973. (b) Altman, R.A.; Shafir, A.; Choi, A.; Lichtor, P.A.; Buchwald. S. 
L., An improved Cu-based catalyst system for the reactions of alcohols 
with aryl halides, J. Org Chem., 2008, 73, 284. 
24. (a) Okano, K.; Tokuyama, H.; Fukuyama, T., Synthesis of secondary 
arylamines through copper-mediated intermolecular aryl amination, Org. 
Lett. 2003, 5, 4987-4990. (b) Finerty, M. J.; Bingham, J. P.; Hartley, J. A.; 
Shipman, M., Azinomycin bisepoxides containing rigid aromatic 
linkers:synthesis cytotoxicity and DNA interstand cross-linking activity, 
Tetrahedron Lett. 2009, 50, 3648-3650. 
25. (a) Mehmood, A.; Leadbeater, N. E., Copper-catalyzed direct preparation 
of phenols from aryl halides, Catal. Commun. 2010, 12, 64. (b) Yang, D.; 
Fu, H., A simple and practical copper catalysed approach to substituted 
phenols from ary halides by using water as the solvent, Chem. Eur. J., 
2010, 16, 2366. (c) Jing, L.; Wei, J.; Zhou, L.; Huang, Z.; Li, Z.; Zhou, X., 
Lithium pipecolinate as a facile and efficient ligand for copper-catalyzed 
hydroxylation of aryl halides in water, Chem. Commun., 2010, 46, 4767. 
(d) Ke, F.; Chen, X.; Li, Z.; Xiang, H.; Zhou, X., Microwave-assisted 
copper-catalyzed hydroxylation of aryl halides in water, RSC Adv., 2013, 3, 
22837. 
26. (a) Ren, Y.; Cheng, L.; Tian, X.; Zhao, S.; Wang, J.; Hou, C., Iron-
catalyzed conversion of unactivated aryl halides to phenols in water, 
Tetrahedron, Lett., 2010, 51, 43. (b) Yang, K.; Li, Z.; Wang, Z.; Yao, Z.; 
Jiang, S., Highly efficient synthesis of phenols by copper-catalyzed 





27. (a) Tlili, A.; Xia, N.; Monnier, F.; Taillefer, M., A very simple copper-
catalyzed synthesis of phenols employing hydroxide salts, Angew. Chem. 
Int. Ed., 2009, 48, 8725. (b) Zhao, D.; Wu, N.; Zhang, S.; Xi, P.; Su, X.; 
Lan, J.; You, J., Synthesis of phenol, aromatic ether, and benzofuran 
derivatives by copper-catalyzed hydroxylation of aryl halides, Angew. 
Chem. Int. Ed., 2009, 48, 8729. (c) Paul, R.; Ali, M. A.; Punniyamurthy, 
T., Copper-catalyzed hydroxylation of aryl halides with 
tetrabutylammonium hydroxides: Synthesis of substituted phenols and 
alkyl aryl ethers, Synthesis, 2010, 4268. (d) Chen, J.; Yuan, T.; Hao, W.; 
Cai, M., Simple and efficient CuI/PEG-400 system for hydroxylation of 
aryl halides with potassium hydroxide, Catal. Commun., 2011, 12, 1463.   
28. Kim, J. W., Cu-catalyzed synthetic process for acetaminophen from 
dihalobenzenes, Dissertation Seoul National University, 2013. 
29. Xiang, S.-K.; Zhang, D.-X.; Hu, H.; Shi, J.-L.; Liao, L.-G.; Feng, C.; 
Wang, B.-Q.; Zhao, K.-Q.; Hu, P.; Yang, H.; Yu, W.-H., Synthesis of N-
arylamides by copper-catalyzed amination of aryl halides with nitriles, 
Adv. Synth. Catal. 2013, 355, 1495-1400 
30. Seo, H. M.; Park, Y. G.; Song, B. S.; Noh, H. D., Method for 
manufacturing phenylenediamine containing recovery process of iodine. 











List of 1H-NMR Spectra of Selected Compounds 
1. 600 MHz 1H-NMR spectrum (CDCl3, 40 oC) of A22-Phe ............. 136 
2. 600 MHz 1H-NMR spectrum (CDCl3, 40 oC) of A22-Leu ............. 137 
3. 400 MHz 1H-NMR spectrum (CDCl3, 50 oC) of A23-Phe ............. 138 
4. 400 MHz 1H-NMR spectrum (CDCl3, 50 oC) of A23-Leu ............. 139 
5. 400 MHz 1H-NMR spectrum (CDCl3, 50 oC) of A23-Val .............. 140 
6. 400 MHz 1H-NMR spectrum (CDCl3, 50 oC) of A23-Ala .............. 141 
7. 400 MHz 1H-NMR spectrum (CDCl3, 50 oC) of A23-Ser .............. 142 
8. 400 MHz 1H-NMR spectrum (CDCl3, 50 oC) of A24-Phe ............. 143 
9. 400 MHz 1H-NMR spectrum (CDCl3, 50 oC) of A24-Leu ............. 144 
10. 400 MHz 1H-NMR spectrum (DMSO-d6) of (2S,3R)-AHPBA .... 145 
11. 400 MHz 1H-NMR spectrum (MeOH-d4) of (2S,3R)-AHMHA ... 146 
12. 400 MHz 1H-NMR spectrum (CDCl3) of ent-A25-Phe ................ 147 
13. 400 MHz 1H-NMR spectrum (CDCl3) of A28-Phe ...................... 148 
14. 400 MHz 1H-NMR spectrum (CDCl3) of A28-Phe’-Val .............. 149 
15. 400 MHz 1H-NMR spectrum (CDCl3) of A28-Leu ...................... 150 
16. 400 MHz 1H-NMR spectrum (CDCl3) of A28-Val ....................... 151 
17. 400 MHz 1H-NMR spectrum (MeOH-d4) of A29 ......................... 152 
18. 400 MHz 1H-NMR spectrum (MeOH-d4) of A30 ......................... 153 
19. 400 MHz 1H-NMR spectrum (CDCl3) of A31 .............................. 154 
20. 400 MHz 1H-NMR spectrum (CDCl3) of A32 .............................. 155 
21. 400 MHz 1H-NMR spectrum (CDCl3) of A33 .............................. 156 




23. 400 MHz 1H-NMR spectrum (CDCl3) of ent-A34 ........................ 158 
24. 400 MHz 1H-NMR spectrum (DMSO-d6) of A35......................... 159 
25. 400 MHz 1H-NMR spectrum (DMSO-d6) of N-(4-Iodophenyl)-
acetamide ............................................................................................. 160 
26. 400 MHz 1H-NMR spectrum (DMSO-d6) of N-(4-Bromophenyl)-
acetamide ............................................................................................. 161 
27. 400 MHz 1H-NMR spectrum (DMSO-d6) of N-(4-Chlorophenyl)-
acetamide ............................................................................................. 162 
28. 400 MHz 1H-NMR spectrum (DMSO-d6) of N-(4-Fluorophenyl)-
acetamide ............................................................................................. 163 
29. 400 MHz 1H-NMR spectrum (DMSO-d6) of N-(4-Nitrophenyl)-
acetamide ............................................................................................. 164 
30. 400 MHz 1H-NMR spectrum (DMSO-d6) of N-(4-Methoxyphenyl)-
acetamide ............................................................................................. 165 
31. 300 MHz 1H-NMR spectrum (DMSO-d6) of N-(4-Hydoxyphenyl)-














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































List of 13C-NMR Spectra of Selected Compounds 
1. 150 MHz 13C-NMR spectrum (CDCl3) of A22-Phe ....................... 136 
2. 150 MHz 13C-NMR spectrum (CDCl3) of A22-Leu ....................... 137 
3. 100 MHz 13C-NMR spectrum (CDCl3) of A23-Phe ....................... 138 
4. 100 MHz 13C-NMR spectrum (CDCl3) of A23-Leu ....................... 139 
5. 100 MHz 13C-NMR spectrum (CDCl3) of A23-Val ........................ 140 
6. 100 MHz 13C-NMR spectrum (CDCl3) of A23-Ala ........................ 141 
7. 100 MHz 13C-NMR spectrum (CDCl3) of A23-Ser ........................ 142 
8. 100 MHz 13C-NMR spectrum (CDCl3) of A24-Phe ....................... 143 
9. 100 MHz 13C-NMR spectrum (CDCl3) of A24-Leu ....................... 144 
10. 100 MHz 13C-NMR spectrum (DMSO-d6) of (2S,3R)-AHPBA ... 145 
11. 100 MHz 13C-NMR spectrum (MeOH-d4) of (2S,3R)-AHMHA .. 146 
12. 100 MHz 13C-NMR spectrum (CDCl3) of ent-A25-Phe ............... 147 
13. 100 MHz 13C-NMR spectrum (CDCl3) of A28-Phe ..................... 148 
14. 100 MHz 13C-NMR spectrum (CDCl3) of A28-Phe’-Val ............. 149 
15. 100 MHz 13C-NMR spectrum (CDCl3) of A28-Leu ..................... 150 
16. 100 MHz 13C-NMR spectrum (CDCl3) of A28-Val ...................... 151 
17. 100 MHz 13C-NMR spectrum (MeOH-d4) of A29 ........................ 152 
18. 100 MHz 13C-NMR spectrum (MeOH-d4) of A30 ........................ 153 
19. 100 MHz 13C-NMR spectrum (CDCl3) of A31 ............................. 154 
20. 100 MHz 13C-NMR spectrum (CDCl3) of A32 ............................. 155 
21. 100 MHz 13C-NMR spectrum (CDCl3) of A33 ............................. 156 
22. 100 MHz 13C-NMR spectrum (DCl) of L-TBOA ......................... 157 




24. 100 MHz 13C-NMR spectrum (DMSO-d6) of A35 ....................... 159 
25. 100 MHz 13C-NMR spectrum (DMSO-d6) of N-(4-Iodophenyl)-
acetamide ............................................................................................. 160 
26. 100 MHz 13C-NMR spectrum (DMSO-d6) of N-(4-Bromophenyl)-
acetamide ............................................................................................. 161 
27. 100 MHz 13C-NMR spectrum (DMSO-d6) of N-(4-Chlorophenyl)-
acetamide ............................................................................................. 162 
28. 100 MHz 13C-NMR spectrum (DMSO-d6) of N-(4-Fluorophenyl)-
acetamide ............................................................................................. 163 
29. 100 MHz 13C-NMR spectrum (DMSO-d6) of N-(4-Nitrophenyl)-
acetamide ............................................................................................. 164 
30. 100 MHz 13C-NMR spectrum (DMSO-d6) of N-(4-
Methoxyphenyl)-acetamide ................................................................. 165 
31. 100 MHz 13C-NMR spectrum (DMSO-d6) of N-(4-



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































국 문 초 록 
 학번: 2011-30278 
이름:서  영  란 
본 논문에서는 N-하이드록시메틸기를 갖는 안정한 a-아미노 
알데하이드를 β-아미노-a-하이드록시산을 입체선택적으로 
합성하는데에 활용한 합성법을 보고함과 동시에, 본 합성법을 
활용하여 N-하이드록시메틸기를 갖는 다양한 a-아미노 
알데하이드로부터 생리활성을 갖는 물질을 합성한 예들도 보고하고 
있다. β-아미노-a-하이드록시산은 높은 입체선택성을 갖으며 
합성되는데, 이는 a-아미노 알데하이드와 
페닐설포닐나이트로메테인의 반응을 통한 N-하이드록시 메틸기의 
분자내 첨가반응을 통해 가능하였고, 합성된 β-아미노-a-
하이드록시산의 절대배열은 두 개의 알려진 β-아미노-a-
하이드록시산의 합성을 통하여 확인되었다. 정립된 합성법은 
아미노펩티데이지의 억제제로 알려진 베스타틴을 합성하는데 
적용되었으며, 적용된 성공적인 펩타이드 합성방법을 토대로 
아이소부틸과 아이소프로필 곁가지를 갖는 베스타틴 유도체를 
처음으로 합성하였다. 이와 더불어, 글루타메이트 차단제인 L-threo-
β-벤질옥시아스팔틱산의 합성도 N-하이드록시메틸기의 분자내 
반응을 통하여 가능하였다. 마지막으로 지금까지 입체선택성이 




아미노-2-하이드록시-4-메틸 펜타노익 산을 포합하는 펩타이드를 
처음으로 합성하였다.  
  본 논문의 후반부에는 아세트아미노펜의 친환경적인 공정에 
관하여 논의 되었다. 새로이 제시된 공정은 파라-
다이할로벤젠으로부터 효율적으로 아세트아미노펜을 합성하는 
방법이 소개되었고, 소개된 공정을 통하여 기존 아세트아미노펜의 
공정이 갖는 문제점이 해결되었으며, 동시에 경제성이 있는 
금속촉매 반응을 통하여 친환경적인 공정환경을 조성할 수 있었다. 
두 단계 반응을 통하여 파라-브로모아이오도벤젠은 N-아세틸-파라-
아미노페놀로 79%의 수율로 전환되었고, 더 간소화된 단일단계 
반응을 통하여 효율성과 경제성을 높임과 동시에 두 단계 
공정에서와 유사한 수율(74%)로 아세트아미노펜을 합성할 수 
있었다. 
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